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1A.  Introduction
The synthesis and characterization of new heterocyclic systems based on
chalcogens  (oxygen, sulfur, selenium, tellurium) has been one of the central
objectives in contemporary organic chemistry.  Several interesting systems
have been synthesized and characterized.  Especially, sulfur-based heterocyclic
systems have found widespread applications in modern material science and
medicinal chemistry [1].
Tetrathiafulvalenes (TTF; Figure 1) and related heterocycles have received
much interest due to their unique electron-donating capabilities [2].  A number
of interesting  properties of  the TTF moiety includes its ability to form
molecular metals and superconductors at low temperatures.  It has also been
incorporated in a number of macrocyclic systems for use as molecular sensors,
enzyme biosensors, switches, wires and shuttles, exploiting the inherent
electron donor properties [3].
Figure 1.  Structure of tetrathiafulvalene (TTF) 1.
However, the biological importance of sulfur-containing heterocycles is still
minor compared to the very wide applications of sulfur-based heterocycles in
modern materials chemistry [1].  No studies have been made so far on the
possible application of TTF to biological systems.  Since biological assays are
routinely done in aqueous media, the solubility of TTF in an aqueous medium
S
S
S
S
1
2could pose a problem.  Its solubility in water is extremely low [4].  In 1998, in a
thesis by Alea, water-soluble TTF derivatives containing sugars were
synthesized [5], which could be tested in biological systems.
This thesis deals with the synthesis of derivatives containing TTF and
carbohydrate moieties.  TTF in combination with carbohydrate molecules could
possibly participate in a number of processes in the human body.  Different
metabolic pathways utilizing redox reactions can be influenced.  Moreover, TTF
derivatives are planar [2] and therefore might possibly intercalate with DNA or
even influence membrane transport. These properties could be of use in the
treatment of diseases or affect metabolic pathways.  As such, part of this thesis
deals with the performance of a MTT assay using SK-N-LO and SK-N-SH
neuroblastoma cell lines to investigate the activity of the synthetic TTF-
carbohydrate derivatives.
A.I.  Review of Related Literature
A.I.1.  Tetrathiafulvalene and related compounds
Only a very limited number of non-metals can be used by biological systems as
a reversible redox switch, and sulfur is one of those [6].  It can be attached to
different biomolecules.  One of the examples, are iron/sulfur proteins.  These
function mainly as a part of electron transfer wires e.g.: in the energy-
transducing respiratory chain of the mitochondria.  Sulfur-based heterocycles
are central building blocks of the chemistry of life [1] as is illustrated in Table
1.
3Table 1. Some key functions of  sulfur in biology [6].
Function Example
Thiolate as a base Thiol proteases
Thiol as a ligand Metal-ion binding
Sulfide as a ligand Metal-ion binding in clusters
Sulfide as a redox group Lipoic acid
Thiolate in group transfer Transfer of acetyl (CoA)
-S-S- as a cross link Many extracellular enzymes
-S-S- in controls Thioredoxine, glutathione
-S-CH3 ether as a ligand and
cross link
Cytochrome C
-S-CH3 ethers (methyl transfers) Coenzyme (methionyl CoA), coenzyme M
Coenzyme catalysis Biotin, thiamin, lipoic acid
Inhibitors (drugs) Penicillin
Among the sulfur-containing heterocycles, tetrathiafulvalene, 2-(1,3-dithiol-2-
ylidene)-1,3-dithiole (TTF) derivatives have been the most intensively studied
species during the past 25 years [7-12].  Its utility as building blocks in
macromolecular and supramolecular structures [13-16], as ferromagnetic
compounds [17] , as synthetic intermediates in organic chemistry [18-19], as a
donor moiety in intramolecular donor-acceptor systems in nonlinear optic
(NLO) materials , as well as in the preparation of liquid crystalline materials
and Langmuir-Blodgett (LB) films [20-22],  are only some applications,
mentioned here.
The unique combination of properties which makes TTF a versatile component
of materials is summarized as follows: (1) is a nonaromatic 14 p-electron
system [23] in which oxidation can occur reversibly in two discrete steps with
the formation of a radical cation (2) and a dication (3) ( Scheme 1 [24]).
4Scheme 1.   Reversible oxidations of tetrathiafulvalene [24].
The redox potentials are relatively low with  E ½ 1 = 0.34 and E 1/2 2 = 0.78 V vs
Ag/AgCl in MeCN [23].  The potential can be finely tuned by the attachment of
the appropriate substituents on the ring system [25].  The TTF cation radical is
thermodynamically very stable due to the contribution from a 6p electron
heteroaromaticity of the 1,3-dithiolium ion [26].  It is stable to synthetic
transformations, but it is important to avoid strongly acidic conditions and
strong oxidizing agents [27]. A number of synthetic pathways have already
been performed  to synthesize the TTF core as shown in scheme 2 [28].
The use of 1,3-dithiole-2-thione-4,5-dithiolate or dimercaptoisotrithione (DMIT)
(4)[29] is considered to be a key intermediate in the synthesis of TTF derivatives
[28].  The name DMIT is a remnant from the nomenclature of the early days of
heterocyclic sulfur chemistry [1].
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5Scheme 2.  Synthetic pathways for tetrathiafulvalene synthesis [28].
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6Scheme 3 surveys the various pathways in the synthesis of DMIT [28].
Scheme 3.  Synthetic pathways for dimercaptoisotrithione synthesis [28].
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7The synthesis of choice for preparing DMIT is the DMF-mediated reduction of
CS2 by sodium metal followed by its isolation as zinc chelate,
bis(tetraethylammonium)bis(1,3-dithiole-2-thione-4,5-dithiolato)zincate, was
mainly developed in the laboratory of Hoyer [30].
A.I.2.  MTT Assay
The non-radioactive, colorimetric assay system using MTT was first described
by Mossman and co-workers [31].  It is used for the measurement of cell
proliferation in response to growth factors, cytokines and nutrients as well as
for the measurement of cytotoxocity.  It can also be used to study cell
activation [32].  MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium
bromide (5), is a yellow tetrazolium salt which can be transformed into purple
colored formazan crystals (6) by metabolic active cells.  This cellular reduction
involves the pyridine nucleotide cofactors NADH and NADPH [33] (Scheme 4).
The larger the number of mitochondria, the more MTT will be transformed into
formazan.  The formazans are purple crystals which are difficult to dissolve.
Prior to measurement, it is first dissolved in isopropanol and the released,
dissolved formazan reagent is measured spectrophotometrically.  The
photometric measurement of a 96-well plate is performed with an ELISA
reader.  Since reduction of MTT can only occur in metabolically active cells, the
level of activity is a measure of the viability of the cells.
MTT provides sensitive and reproducible indices of growth as well as drug
sensitivity in individual cell lines over the course of multiple passages and
several months of cultivation.  It is suitable for initial stage in vitro drug testing
[34].
8Scheme 4.  Metabolization of MTT (5) to a formazan salt (6) by viable cells [33].
A.I.3.  Doxorubicin
Doxorubicin hydrochloride (7), with the common name adriamycin, is named
according to IUPAC nomenclature:  (8S,10S)-10-[(3-amino-2,3,6-trideoxy-a-L-
lyxo-hexopyranosyl)oxy]-8-glycolyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-me-
thoxy-5,12-naphthacenedione hydrochloride.
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Figure 2.  Structure of doxorubicin (7).
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9Doxorubicin (7) is a cytotoxic anthracycline antibiotic, isolated from cultures of
Streptomyces peucetius var. caesius.  It consists of a naphthacenequinone
nucleus linked through a glycosidic bond at ring atom 10 to an amino sugar,
daunosamine.  The cytotoxic effect of (7) on malignant cells and its toxic effects
on various organs are among others thought to be related to its nucleotide base
intercalation, presumably by specific intercalation of the planar anthracycline
nucleus with the DNA double helix.  Intercalation inhibits nucleotide
replication and action of DNA and RNA polymerases.  7 also binds to cell
membranes as well as plasma proteins.  Its binding may effect a variety of
cellular functions.  Enzymatic electron reduction of 7 by a variety of oxidases,
reductases and dehydrogenases generate highly reactive species including the
hydroxyl free radical OH.  Free radical formation has been implicated in its
cardiotoxicity by means of Cu(II) and Fe(III) reduction at the cellular level [35].
A.I.4.  Neuroblastoma
Cancer in children and adolescents is rare, but it is the leading cause of death
from disease in children between the ages of 1 and 19.  Neuroblastoma
accounts for 97% of the cancers of the sympathetic nervous system which
comprises one of the twelve major categories of the International Classification
of Childhood Cancers (ICCC) [36].
It is predominantly a tumor of early childhood, with two-thirds of the cases
presenting in children younger than five years of age [37].  It is a solid tumor
cancer that originates in the adrenal medulla or the paraspinal sites where
sympathetic nervous tissue is located.
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The most common symptoms are due to a tumor mass or to bone pain from
metastases.  Occassionally, fever, anemia and hypertension are present.  One
of the rare symptoms is severe watery diarrhea due to secretion of vasoactive
intestinal peptide by the tumor [37].
Diagnosis requires specialists who are expert in childhood tumors, because
some neuroblastomas are hard to discriminate from other small round blue
cells of childhood by conventional light microscopy.  Evidence for sympathetic
neuronal differentiation may be demonstrated by immunohistochemistry,
electron microscopy, or by finding elevated levels of serum catecholamines
(dopamine, norepinephrine) or urine catecholamine metabolites:
(vanillamandelic acid (VMA) or homovanillic acid (HVA)).  The minimum
criterion for diagnosis established by international agreement is based on one
of the following:  1) an unequivocal pathologic diagnosis made from tumor
tissue by light microscopy; 2) the combination of bone marrow aspirate or
trephine biopsy containing distinct tumor cells;  3) increased levels of serum or
urinary catecholamines  [38].  But nearly 70% of those children first diagnosed
have a disease that has already metastasized to other parts of the body.  The
average age at diagnosis is two years old  [36].
The treatment ranges from surgery, chemotherapy to radiation therapy alone or
in some combination depending on the stage of the disease.  Under evaluation
are: monoclonal antibody therapy [39], myeloablative therapy and stem cell
transplantation.  The chemotherapeutic agents most commonly used include
carboplatin, cyclophosphamide, doxorubicin, cisplatin, vincristine and
teniposide or etoposide [38].  Furthermore, neuroblastoma can be detected by
11
scintigraphy, using the radiolabelled catecholamine-related substance meta-
iodobenzylguanidine [123I]mIBG.
Prognosis for neuroblastoma is dependent on age, stage of disease and the
molecular biologic and cytogenetic characteristics of the tumor.  There is very
little known about why it occurs or about what factors increase the risk for
occurrence [36].
Important research into neuroblastoma is under way right now all over the
world.  Scientists try to find out more about the disease, its prevention and
improved treatment.
A.I.4.1.  Adherently growing human neuroblastoma cell lines
The potential usefulness in cancer research of continous cell lines, established
in vitro from human tumors is widely accepted [40].  Two human
neuroblastoma cell lines were used in the experiment, namely: SK-N-SH and
SK-N-LO.
SK-N-LO is a human cell line of neuroectodermal origin.  It has no detectable
DOPA-decarboxylase, the enzyme responsible for formation of dopamine [41].
SK-N-SH is a typical neuroblastoma cell line established and described by
Biedler and her co-workers [40].  Aside from DOPA-decarboxylase, it also
contains dopamine-b-hydroxylase, responsible for the production of
norepinephrine [41].
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B.  Results and Discussion
B.I.  Synthesis of Starting Materials
B.I.1. Synthesis of 2,3,6,7-tetrakis(2’-cyanoethylthio)tetrathiafulvalene
(12)
The synthesis of a TTF derivative may proceed via numerous pathways.  At
present, the most common synthetic strategy for the preparation of
structurally-modified TTFs is the direct coupling via desulfurization of modified
1,3-dithiole-2-thione-4,5-dithiolate or dimercaptoisotrithione (DMIT) 4, by
using trivalent phosphorus compounds (tri-alkyl/aryl/phenyl phosphites).  It
provides subs- tantial yield (40-90%) of the derivatized-TTF [29].
S S
SS
S
4
Figure 3.  Structure of 1,3-dithiole-2-thione-4,5-dithiolate (dimercaptoisotri-
thione, DMIT) (4).
However, the DMIT salts (Li, Na, and K) are all air- and moisture-sensitive . It is
also unstable in acidic media and consequently cannot be isolated in its
protonated neutral form [1].  The synthesis of choice for preparing DMIT is the
DMF-mediated reduction of CS2 by sodium metal followed by its isolation as
zinc chelate, bis(tetraethylammonium)bis(1,3-dithiole-2-thione-4,5-dithiolato)-
zincate (8), mainly developed in the laboratory of Hoyer [30].  The mechanism
by which CS2 is reduced is as follows:
13
Scheme 5. Mechanism of carbon disulfide reduction by sodium.
The production of bis(tetraethylammonium)bis(1,3-dithiole-2-thione-4,5-dithio-
lato)zincate (8) as shown in Scheme 6,  gave a yield of 80%.
Sulfur nucleophiles are known to be among the most powerful heteroatom
nucleophiles known. The zinc chelate and the DMIT salts are possible sources
of nucleophilic synthons, although the zinc chelate is a less reactive substitute
for the DMIT salts.
One can take advantage of the nucleophilicity by the use of protecting groups.
Various studies have been done on possible protecting groups that can
withstand the rigorous desulfurization coupling conditions of the thione/oxone
precursors whose facile deprotection under basic/weakly acidic conditions
generates the TTF mono-/di-/tetra- thiolates.  However, a number of dithioles
are unable to survive
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Scheme 6.  Preparation of bis(tetraethylammonium)bis(1,3-dithiole-2-thione-
4,5-dithiolato)zincate (8).
the reaction conditions of coupling,  especially systems containing ester-,
thioester/, urethane/, alcohol, or ketone-/aldehyde functionalities.  That
means, no coupling reaction would take place if a sugar moiety is attached to a
DMIT structure as shown also in previous studies [46].  Scheme 7 shows the
trivalent phosphorous coupling to produce TTF.
As such, an alternative route which makes use of a preformed TTF,
tetrathiafulvalene-2,3,6,7-tetrathiolate (9), was done for the synthesis of TTF-
carbohydrate derivatives.
SS
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Figure 4.  Structure of tetrathiafulvalene-2,3,6,7-tetrathiolate (9).
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Scheme 7.  Trivalent phosphorous coupling to TTF.
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A number of precursors to 9 have been reported [42-47]. In this experiment,
the use of 2,3,6,7-tetrakis(2-cyanoethylthio)tetrathiafulvalene (12) [47] as
precursor to 9 was chosen.
12 is prepared in three steps from 8 by alkylation with 3-bromopropionitrile in
refluxing acetonitrile giving 4,5-bis(2’-cyanoethylthio)-1,3-dithiole-2-thione (10)
with 80 % yield.  Mercuric acetate transchalcogenation of 10 gave the
corresponding 4,5-bis(2’-cyanoethylthio)-1,3-dithiol-2-one (11) in near
quantitative yield.  Finally, self-coupling of 11 using triethylphosphite in
refluxing toluene yielded 12 in 70% yield.  (Scheme 8).
12 is an excellent precursor to 9.  Generation of 9 is achieved in quantitative
yields at room temperature [47] by treating 12 with strong bases to afford
cleavage of the cyanoethyl group.  Either NaOMe/MeOH or CsOH·H2O/MeOH
was used for the cleavage reaction.
B.I.2.  Synthesis of benzyl 2,3-anhydro-b -L-ribopyranoside (18) [48]
The synthesis of the compound 18 was successfully performed in 6 steps,
starting from L-arabinose (13) (Scheme 9).  Benzylation of L-arabinose in the
presence of hydrogen chloride leads to the anomerically protected benzyl ß-L-
arabinopyranoside (14) [49].  The cis-oriented hydroxyl groups at C-3 and C-4
were protected via 2,2-dimethoxypropane and p-toluene sulfonic acid (as a
catalyst) in acetone, giving benzyl 3,4-di-O-isopropylidene-ß-L-
arabinopyranoside (15). The free hydroxyl group at C-2 was directly tosylated
with p-toluene sulfonyl chloride in pyridine, affording compound 16. The
isopropylidene protecting group was selectively removed from 16 with 90%
acetic acid to yield 17 [50).
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Scheme 8.  Synthesis of 2,3,6,7-tetrakis(2’-cyanoethylthio)tetrathiafulvalene
(12) from bis(tetraethylammonium)bis(1,3-dithiole-2-thione-4,5-
dithiolato)zincate (8) via 4,5-bis(2’-cyanoethylthio)-1,3-dithiol-2-thione (10) and
4,5-bis(2’-cyano-ethylthio)-1,3-dithiol-2-one (11).
Scheme 9.  Synthesis of benzyl 2,3-anhydro-b-L-ribopyranoside (18) from L-
arabinose (13) via benzyl b-L-arabinopyranoside (14), benzyl 3,4-O-isopro-
pylidene-ß-L-arabinopyranoside (15), benzyl 3,4-O-isopropylidene-2-O-p-
tolylsul-fonyl-ß-L-arabinopyranoside (16) and benzyl 2-O-p-tolylsulfonyl-ß-L-
arabinopyranoside (17).
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The target compound 18 was finally obtained by the action of sodium
methoxide in methanol on compound 17, followed by the neutralization with
dilute hydrochloric acid.
B.I.3.  Synthesis of benzyl 2,3-anhydro-4-O-triflyl-ribopyranoside (19) [48]
The triflation of the free hydroxyl group in 18 was achieved at low temperature
(-20°C) by treatment with trifluoromethanesulfonic anhydride in
dichloromethane.  The triflate 19 was obtained in high yield upon work-up at
0°C (Scheme 10).
Scheme 10.  Synthesis of benzyl 2,3-anhydro-4-O-triflyl-ß-L-ribopyranoside
(19) from benzyl 2,3-anhydro-ß-L-ribopyranoside (18) [48].
B.I.4.  Synthesis of 2,3,4,6-tetra-O-acetyl-a-D-glucopyranosylbromide (22)
[51]
The synthesis of compound 22 was done in 2 steps, starting from the
commercially available D-glucose (20).  Acetylation of 20 in the presence of
acetic anhydride/NaOAc leads to 1,2,3,4,6-penta-O-acetyl-b-D-glucopyranoside
(21).  Then, 45% HBr/HOAc was added to compound 21 to brominate the
anomeric position, giving 22 with a yield of 89.5% (Scheme 11).
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Scheme 11.  Synthesis of 2,3,4,6-tetra-O-acetyl-a-D-glucopyranosyl bromide
(22), from D-glucose (20), via 1,2,3,4,6-penta-O-acetyl-b-D-glucopyranoside
(21).
B.I.5.  Synthesis of 1,2,3,4-tetra-O-acetyl-6-deoxy-6-iodo-a-D-glucopyrano-
side (25) [52]
The primary hydroxyl group at C-6 in methyl a-D-glucopyranoside (23) was
transformed into an iodo group upon treatment with triphenylphosphine,
imidazole and iodine in toluene at 70°C.  Further treatment with acetic
anhydride and pyridine produced methyl 2,3,4-tri-O-acetyl-6-deoxy-6-iodo-a-
D-glucopyra-noside (24).  The anomeric position was then acetylated by the
use of Ac2O/HOAc giving 25 upon work-up (Scheme 12).
Scheme 12.  Synthesis of 1,2,3,4-tetra-O-acetyl-6-deoxy-6-iodo-a-D-gluco-
pyranoside (25), from methyl a-D-glucopyranoside (23), via methyl 2,3,4-tri-O-
acetyl-6-deoxy-6-iodo-a-D-glucopyranoside  (24).
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B.II.  Synthesis of Tetrathiafulvalene-Carbohydrate Conjugates
Synthesis of the TTF derivatives made use of a tetrathiolate nucleophile first
synthesized by Svenstrup [53] and his group in 1995.  2,3,6,7-tetra(2’-
cyanoethylthio)tetrathiafulvalene (12), generates the tetrathiathiolate upon
deprotection using basic conditions.  The course of the reaction depends on the
conditions, the nature of the electrophilic sites or the geometry of the
electrophile [1].  The major problem encountered with the synthesis of the
derivatives had to do with obtaining the products in moderate to high yield and
the reproducibility of the results [54].  Different solvent systems and reaction
conditions were used to optimize the results.   Solvent plays a major role in
most reactions [55].  Acetone, acetonitrile, methanol and DMF were tried for
the reactions.  Qualitative analysis of the products by TLC was performed to
identify the solvent for optimal yield and little by-products.  Carbohydrates of
different stereochemistry and functionalization were used for the synthesis of
the tetrathiafulvalene-carbohydrate conjugates.
The reaction of 12 with benzyl 2,3-anhydro-4-O-triflyl-ß-L-ribopyranoside (19),
was performed first to get information about the feasibility of the reaction.
Then, glucose (20) was protected by acetyl residues at different ring positions.
Glucose was chosen because of it’s wide availability and it’s central role in
biochemistry.  Acetate as a protecting group was chosen, since the sugar can
be deprotected under basic conditions whereby TTF is stable [1].  The
syntheses made use of 22 with a bromo group at the anomeric position, 25
with an iodo group at position 6, and 3,4,6-tri-O-acetyl-D-glucal (26) with a
double bond between positions 1 and 2.
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Figure 5.  Structure of 3,4,6-tri-O-acetyl-D-glucal (26).
CsOH·H2O in methanol and NaOMe in methanol were both used for the
deprotection step.  The reaction mixture proved to be very sensitive to the ratio
of base used for deprotection.  Moreover, a large excess of base is avoided
because an excess could compete with the reaction of the thiolate with the
carbohydrate moiety, in particular, deacetylation, producing a mixture of
products.  After preliminary experiments, the use of CsOH?H2O is favoured,
because of easier control in the number of equivalents used and yielding less
side products compared to NaOMe/MeOH.
Deprotection of cyanoethyl groups proceeds via elimination:  The base
abstracts the alpha (a) proton neighbouring the cyano group, causing double
bond formation generating the thiolate, acrylonitrile, and a protonated base.
The acrylonitrile side product is volatile and can be conveniently removed in
vacuo.  The resonance stabilization of the tetrathiafulvalene tetrathiolate makes
it a powerful nucleophile [56].
The reaction with the carbohydrate moieties proceeded via nucleophilic
substitution with the tetrathiolate ion.
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Scheme 13.  Mechanism of tetrathiafulvalene-2,3,6,7-tetrathiolate (9), forma-
tion from 2,3,6,7-tetrakis(2’-cyanoethylthio)tetrathiafulvalene (12) under basic
conditions.
The three sites identified for sugar attachment are:  C-4 in 19,  the anomeric
carbon (C-1)  in 22 and 26, and the primary carbon (C-6) in 25.  Although the
anomeric carbon is the most reactive site in the sugar molecule followed by the
least sterically hindered carbon 6, the structure of 19 made C-4, a more
reactive site than the two because of the presence of the anhydro group in C-2
and C-3 and triflate in C-4 as the leaving group.
B.II.1.  Synthesis of 2,3,6,7-bis(benzyl 3’,4’-dithio-a -D-arabinopyranosyl)-
tetrathiafulvalene (27)
The synthesis of 2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-arabinopyranosyl)tetrathia-
fulvalene (27) was performed to know the feasibility of reacting a TTF molecule
to a carbohydrate moiety.  12 was deprotected using 4 equivalents of
CsOH°H2O followed by the addition of 19.  Compound 19 contains the anhydro
group functioning for both, as a protecting group and activator of position 4 of
the sugar which in turn contains a very good leaving group, the triflate.  It is
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known that structures in which the anhydro group is between adjacent carbon
atoms are generally too reactive.  Ring opening could take place upon reaction
with nucleophiles.  The relief of ring strain is great enough that reaction could
take place under relatively mild conditions [57].  From the results, the
nucleophilic displacement of the triflyl group at C-4’ by sulfur was followed by
the simultaneous intramolecular ring opening of the epoxide to afford 2,3,6,7-
bis(benzyl 3’,4’-dithio-a-D-arabinopyranosyl)tetrathiafulvalene (27) in 80%
yield.  Flash column chromatography using 10% EtOAc in DCM afforded yellow
orange powder with a melting point of 90.5°-92.0°C and [ ]25Da  = +37.66 (c =
0.10, DCM).
The structure of the product was established through IR, MS, 1H and 13C NMR
spectroscopy and elemental analysis.
The infrared spectrum gives the following structural information:  OH (3450
cm-1 associated OH stretching), phenyl ring, probably monosubstituted (2000 –
1600 cm-1 combination vibrations, 1500 cm-1, 698 cm-1, skeletal vibrations),
olefinic carbon ( 3029 cm-1, C-H stretching, 1605 and 1495 cm1- , C=C
stretching).  The signal in the mass spectrum at m/z 740, is probably the
molecular ion.  The fragment m/z 329 corresponds to [M+ H+- 2(C12H14O3]]
(C12H14O3 = carbohydrate component), while m/z 207.1 corresponds to [M + H+
- C6S8] (C6S8 = tetrathiafulvalene-tetrathiolate component).  These, suggests the
attachment of two carbohydrate moieties in the molecule and the absence of
the ethylcyano leaving group.
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Figure 6.  IR spectrum of 2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-arabinopyranosyl)-
tetrathiafulvalene (27) recorded in KBr. Interpretation of the important bands
(cm-1):  3450, OH;  2000 –1600, arC-H;  1605, 1495 C=C.
Figure 7.  MS-FAB spectrum of 2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-arabinopy-
ranosyl)tetrathiafulvalene (27), Interpretation of the important fragments:
(matrix NBA at T=50°C) m/z:  740.9 [M + H+], 739.9 [M], 329.1 [M+ H+-
2(C12H14O3]] (C12H14O3 = carbohydrate component), 307.1 [matrix], 207.1 [M +
H+ - C6S8] (C6S8 = tetrathiafulvalenetetrathiolate component).
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The 13C NMR spectrum of 27 shows a new signal at d = 119.09 ppm besides
the usual signals for the gluco moieties.  This could infer the signal of the
olefinic carbon due to presence of the TTF moiety in the molecule (Table 2).
Indicative information about the structure of 27 can be received also from its
1H NMR spectrum.  The conformation adopted by the pyranoside ring in 27
was determined by the vicinal coupling constants and chemical shifts in the 1H
NMR spectrum.  5’-H and 5’’-H were recognized from their large geminal
coupling constant (~12 Hz) at d = 4.61 and 4.18 ppm respectively.  A
symmetrical ddd pattern appeared for H-4’ with J4’,5’ = 8.0, J4’,5’’ = 3.0 and J3’,4’
= 10.0.  This indicates an axial-axial relation between H-4’ and H-5’ and a
quasi equatorial-axial relationship between H-4’ and H-5’’; conformation is,
therefore predominantly 1C4.   This is further supported by large axial-axial
coupling (J1,2 = 7.5 Hz) for H-1’ and H-2’.
Table 2.  13C chemical shift assignment of 2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-
arabinopyranosyl)tetrathiafulvalene (27).
Carbon chemical shift (d ppm) Assignment
138.84 C6H5
128.61, 128.52, 128.40 C6H5
119.09 C=C
104.04 C-1’
95.20 C-2’
70.89 OCH2Ph, (B)
56.16 C-3’
52.23 C-5’
50.66 C-4’
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Table 3.  1H NMR chemical shifts of 2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-arabino-
pyranosyl)tetrathiafulvalene (27).
Proton
chemical shift
(d ppm)
Integration Multiplicity Coupling
constant,
J (Hz)
Assignment
7.29-7.36 5H m C6H5
4.93 1H d 12 OCHHPh
4.80 1H d 12 OCHHPh
4.61 1H dd 8, 12 H-5’
4.47 1H d 7.5 H-1’
4.18 1H dd 4, 12 H-5’’
3.92 1H ddd 4, 7, 10 H-4’
3.65 1H dd 5, 7.5 H-2’
3.56 1H dd 5, 10 H-3’
CsOH.H2O
19, 12 h
rt, 80%
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Scheme 14.  Synthesis of 2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-arabinopyranosyl)-
tetrathiafulvalene (27) from 2,3,6,7-tetrakis(2’-cyanoethylthio)tetrathiafulvalene
(12) via tetrathiafulvalene-2,3,6,7-tetrathiolate, (9).
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B.II.2.  Synthesis of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-tetra-O-
acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28) and 2,6-bis(2’’-
cyanoethylthio)-3,7-bis(2’,3’,4’,6’-tetra-O-acetyl-1’-thio-b -D-glucopyrano-
syl)tetrathiafulvalene (29)
2,3,4,6-tetra-O-acetyl-a-D-glucopyranosyl bromide (22), and 1,2,3,4-tetra-O-
acetyl-6-deoxy-6-iodo-a-D-glucopyranoside (25) were also used as starting
materials to synthesize the TTF-carbohydrate derivatives.  The anomeric
carbon in 22 is the most reactive site in a sugar molecule followed by the least
sterically hindered primary carbon of 25.
The reaction involves the deprotection of 12, followed by nucleophilic
substitution of 25 to give the product 2,6-bis(2’’-cyanoethylthio)-3,7-
bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28)
in 48.6% yield.  Flash chromatography, using ethylacetate/DCM (1:9) as eluent
yielded a yellow orange powder with a melting point of 186.7-187.0°C, [ ]25Da  =
+101 (c = 0.1, DCM).  Similarly, 22 yielded 2,6-bis(2’’-cyanoethylthio)-3,7-
bis(2’,3’,4’,6’-tetra-O-acetyl-1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (29)
as a brown thick oily liquid in 59.8% yield with [ ]25Da  = -62.55 (c = 0.1, DCM).
The structures of the products were established through infrared, mass, 13C
and 1H NMR spectroscopy.  The infrared spectra of 28 and 29 give the
following structural information:  carbonyl group (1750 cm-1, C=O stretching
vibration, 1200-1000 cm-1, C-O stretching vibration), nitrile group (2240 cm-1,
CºN stretching vibration ), olefinic carbon (2960 cm1- , CH stretching vibration,
1600 and 1400 cm1- C=C stretching vibration). The FAB-MS spectra of 28 and
28
29 show a peak at m/z 1098 which can be assumed as the molecular mass
and there’s the presence of fragment m/z 331 (C14H19O9) that could correspond
to the carbohydrate component.  These suggest the presence of esters due to
the carbohydrate moiety and the cyano group due to TTF in the molecule.
Figure 8.  IR spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-tetra-O-
acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28) recorded in KBr.
Interpretation of the important bands (cm-1): 2200, CºN;  1747, C=O;  1200-
1000, C-O;  2926, C-H; 1600 and 1428, C=C.
Figure 9.  IR spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,4’,6’-tetra-O-
acetyl-1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (29) recorded in KBr.
Inter-pretation of the important bands (cm-1): 2200, CºN;  1747, C=O;  1200-
1000, C-O;  2965, C-H;  1662, 1433, C=C.
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Figure 10.  FAB-MS spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-
tetra-O-acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28). Interpretation
of the important fragments:  (matrix: NBA) m/z: 1098 [M+], 331 = C14H19O9 =
carbohydrate component, 306.8 [matrix ].
Figure 11.  FAB-MS spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,4’,6’-
tetra-O-acetyl-1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (29) in NBA matrix
at T=50°C. Interpretation of the important fragments: (matrix: NBA) m/z:
1120.8 [M+ + 23], 1098 [M+], 767.9 [M+ - C14H19O9] (C14H19O9= carbohydrate
component), 331 = C14H19O9 =carbohydrate component, 307 [matrix].
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Additional information can also be extracted from the 13C NMR spectrum of 28
and 29.  Four carbonyl signals were found at d =170.21 to 168.75 ppm while
four acetyl methyl carbons lead to signals in the narrow range d = 20.85 to d =
20.44 ppm.  This is in good agreement with the presence of esters as was
suggested from the infrared spectrum. There is also the presence of the usual
signals from the gluco moiety.  The mass spectrum fragment at m/z 331 and
the presence of resonances due to the acetylated pyranoside ring illustrate the
presence of the carbohydrate moiety in the molecule. C-6’ of 28 resonates
significantly at higher field at d = 37.21 ppm, and the anomeric carbon of 29 at
d = 84.35 ppm clearly indicate the attachment to a thiol functionality.  The
olefinic carbon signals at d = 117.49 ppm and d = 118.0 ppm for 28 and 29,
respectively, and the presence of resonances at d = 31.40 ppm and d = 18.81
for 28 and d = 32.04 and d = 18.79 for 29 are due to SCH2CH2CN and
SCH2CH2CN, respectively and can be attributed to the TTF component.  From
the assumed molecular mass of 1098 one has to suggest the presence of two
carbohydrate moieties attached to the TTF unit in the molecular structure.
Indicative information about the structure of 28 can be viewed also from its 1H
NMR spectrum.  The 1H NMR spectrum, integrated only half the number of
hydrogen atoms expected from the proposed structure.  The conformation
adopted by the pyranoside ring in 28 is predominantly 1C4 due to equatorial-
equatorial relationship between H-1’ and H-2’ (J = 4 Hz).  Vicinal gauche
protons with a ~60° dihedral angle have small J values between 1-4 Hz.
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Figure 12.  Structure of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-tetra-O-
acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28).
The glucose moiety in 29 adopts the 4C1 as the predominant conformation due
to diaxial relationship between H-1’ and H-2’ ( J = 8 Hz). This high coupling
constant is consistent with protons that have trans diaxial relationship with a
dihedral angle of ~180º. The said conformation is favoured as can be illustrated
by the mechanism in scheme 13.  When bromide departs, influenced by the
presence of cesium to give the oxocarbonium ion, it reacts with C-2’ acetate to
give a more stable dioxocarbonium ion.  Nucleophilic attack of the thiolate salt
results in the ring opening to give a bond trans to the participating acetate [5].
Scheme 15.  Mechanism for the favoured conformation of the glucopyranoside
ring of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,4’,6’-tetra-O-acetyl-1’-thio-b-D-
glucopyranosyl)tetrathiafulvalene (29).
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Figure 13.  Structure of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,4’,6’-tetra-O-
acetyl-1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (29).
Table 4.  13C NMR chemical shifts of 2,6-bis(2’’-cyanoethylthio)-3,7-bis
(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28).
Carbon chemical shift (d ppm) Assignment
170.23, 169.67, 169.59, 168.75 COOCH3
117.50 C=C
88.88 C-1’
70.76 (2C), 69.69, 69.26 C-2’–C-5’
37.29 C-6’
31.40 SCH2CH2CN
20.84, 20.73, 20.68, 20.46 CH3COO
18.82 SCH2CH2CN
Table 5.  1H NMR chemical shifts of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’
-tetra-O-acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28).
Proton
chemical
shift (d  ppm)
Integration Multiplicity Coupling
constant, J
(Hz)
Assignment
6.25 1H d 4 H-1’
5.43 1H t 10 H-3’
5.04 1H dd 4, 10 H-2’
4.88 1H t 10 H-4’
4.05 1H m H-5’
3.11 2H dd 3, 7 SCH2CH2CN
3.05 1H dd 7, 12 H-6’
2.93 1H dd 7, 14 H-6’’
2.71 2H dd 3, 7 SCH2CH2CN
2.17, 2.07,
2.06, 2.01
12H s CH3COO
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Table 6.  13C NMR chemical shifts of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,
4’,6’-tetra-O-acetyl-1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (29).
Carbon chemical shift (d  ppm) Assignment
170.66-169.38 CH3COO
118.86 C=C
82.98 C-1’
74.90 C-2’
72.66 C-3’
69.29 C-4’
67.69 C-2’
61.78 C-6’
31.75 SCH2CH2CN
20.69-20.59 CH3COO
18.19 SCH2CH2CN
Table 7.  1H NMR chemical shifts of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,
4’,6’-tetra-O-acetyl-1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (29).
Proton
chemical
shift (d ppm)
Integration Multiplicity Coupling
constant,
J (Hz)
Assignment
5.22 2H t 9.5 H-3’
5.10 2H t 9.5 H-4’
4.99 2H dd 8, 9.5 H-2’
4.42 2H d 8.0 H-1’
4.28 2H dd 5, 12 H-6a’
4.15 2H dd 3,12 H-6b’
3.72 2H m H-5’
3.27 2H t 6.3 SCH2CH2CN
2.76 2H t 6.3 SCH2CH2CN
2.08 4H s COCH3
2.05 4H s COCH3
2.04 4H s COCH3
1.98 4H s COCH3
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B.II.3.  Synthesis of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-glucopy-
ranosyl)tetrathiafulvalene (30) and 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-
thio-b-D-glucopyranosyl)tetrathiafulvalene (31)
The synthesis of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-glucopyranosyl)-
tetrathiafulvalene (30) and 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-gluco-
pyranosyl)tetrathiafulvalene (31) involved the simple hydrolysis of 28 and 29
using catalytic amounts of NaOMe in methanol.  A quantitative amount of a
brown oily product was produced.  The products were also observed to slowly
turn black upon exposure to the atmosphere.  Not much information was
obtained from the 1H NMR spectrum of 30 and 31 in D2O because of large
water peaks at d 4.60.  However, the infrared spectrum showed the presence of
a big broad band at ~3500 cm1- due to OH group, and the absence of carbonyl
functionality at 1750 cm1-.  The mass spectra for 30 and 31 end at m/z 482.
This maybe assigned to [M- 2(C6H11O5) + 2 Na], where C6H11O5 corresponds to
the glucose moiety.  The fragments at m/z 460 [M – 2(C6H11O5) + Na] and m/z
328 [M – 2(C6H11O5) ] correspond to the TTF moiety.  Therefore, the recovered
water-soluble brown thick oily product was immediately used for the MTT
assay.
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Figure 14.  FAB-MS spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-
glucopyranosyl)tetrathiafulvalene (30) Interpretation of the important
fragments:  (matrix: NBA) m/z: 481.8 [M+- 2(C6H11O5) + 2 Na], C6H11O5 =
glucose moiety, 460 [M+ – 2(C6H11O5) + Na] 307, 289 [matrix].
Figure 15.  FAB-MS spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-
glucopyranosyl)tetrathiafulvalene (31). Interpretation of the important
fragments:  (matrix: NBA) m/z: 482 [M+- 2(C6H11O5) + 2 Na], C6H11O5 = glucose
moiety, 460 [M+ – 2(C6H11O5) + Na] 307, 289 [matrix].
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Scheme 16.  Synthesis of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-
glucopyranosyl)tetrathiafulvalene (30) via tetrathiafulvalene-2,3,6,7-tetra-
thiolate (9) and 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-
thio-a-D-glucopyranosyl)tetrathiafulvalene (28) from 2,3,6,7-tetrakis(2’-
cyanoethylthio)tetrathiafulvalene (12) and 1,2,3,4-tetra-O-acetyl-6-deoxy-6-
iodo-a-D-glucopyranoside (25).
Scheme 17.  Synthesis of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-
glucopyranosyl)tetrathiafulvalene (31) via tetrathiafulvalene-2,3,6,7-tetra-
thiolate (9) and 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,4’,6’-tetra-O-acetyl-1’-
thio-b-D-glucopyranosyl)tetrathiafulvalene (29) from 2,3,6,7-tetrakis(2’-cyano-
ethylthio)tetrathiafulvalene (12) and 2,3,4,6-tetra-O-acetyl-a-D-glucopyrano-
sylbromide (22).
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B.II.4.  Reaction of 2,3,6,7-tetrakis(2’-cyanoethylthio)tetrathiafulvalene
(12) with 3,4,6-tri-O-acetyl-D-glucal (26)
An attempt was made to react 12 with 3,4,6-tri-O-acetyl-D-glucal (26).  26
contains a double bond between positions 1 and 2.  The thiol group is capable
of participation in reactions like addition to double bonds [58].  Two different
mechanisms are possible, nucleophilic and free radical addition.  The rate
might be very slow unless there is a strong base catalyst.  However, based on
the results, a very polar product was obtained, which turned out to be just the
deprotected 26.
Scheme 18.  Reaction of 2,3,6,7-tetrakis(2’-cyanoethylthio)tetrathiafulvalene
(12) with 3,4,6-tri-O-acetyl-D-glucal (26).
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B.II.5.  Synthesis of tetrakis(2’-hydroxyethylthio)tetrathiafulvalene (32)
and 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’-carboxymethylthio)tetrathiaful-
valene (33)
Tetrakis(2’-hydroxyethylthio)tetrathiafulvalene (32) and 2,6-bis(2’’-cyanoethyl-
thio)-3,7-bis(2’-carboxymethylthio)tetrathiafulvalene (33) were synthesized in
an attempt to produce a water-soluble, carbohydrate-free, TTF derivative to be
used for the biological assay.  32 was prepared by deprotecting 12 using
freshly prepared NaOMe.  2-Chloroethanol was added, stirred over a period of
16 hours and this resulted in an orange oil which crystallized after the addition
of hexane to give orange needles with a yield of 90% and a melting point of
142.9-143.6°C (Lit.[52] 139.0-140.0°C).  1H NMR and 13C NMR data are similar
to the literature [52] (Scheme 19).
Scheme 19. Synthesis of tetrakis(2’-hydroxyethylthio)tetrathiafulvalene (32)
via tetrathiafulvalene-2,3,6,7-tetrathiolate (9), from 2,3,6,7-tetrakis(2’-cyano-
ethylthio)tetrathiafulvalene (12) and 2-chloroethanol.
Similarly, 33 was prepared by adding ICH2COOH to deprotected 12 and the
mixture was stirred overnight at room temperature.  This resulted in an orange
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oil, methanol was then added and a red-orange precipitate formed.  This was
filtered to give 82% yield (mp 181-182°C). The FAB-MS spectrum ends at m/z
482 which did not correspond to the expected molecular mass of 544.
However, the next fragment at m/z 460, corresponds to [M – 2(CH2COOH) +
Na], such that m/z 482 is [M – 2(CH2COOH) + 2(Na)].  The 13C NMR spectum of
33 showed the resonances at d = 169.2 ppm, suggesting the presence of a
carbonyl carbon, d = 116.93 ppm, indicative for an olefinic carbon and d =
31.00 and 18.15 ppm, that might be due to a SCH2CH2CN functionality.
Additional information can be deduced from the 1H NMR spectrum which
showed an intense broad peak at d = 3.70 ppm that can be attributed to the
carboxylic acid functionality.  Moreover, the presence of triplets at d = 3.16
ppm (J = 7), and d = 2.88 ppm  (J= 7) confirmed the presence of the
SCH2CH2CN group.  Scheme 20 shows the synthesis for 33.
Table 8.  13C NMR chemical shift of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’-
carboxymethylthio)tetrathiafulvalene (33).
Carbon chemical shift (d ppm) Assignment
169.12 COOH
118.93 C=C
31.00 SCH2CH2CN
18.15 SCH2CH2CN
Table 9.  1H NMR chemical shift of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’-
carboxymethylthio)tetrathiafulvalene (33).
Proton
chemical
shift (d  ppm)
Integration Multiplicity Coupling
constant, J
(Hz)
Assignment
3.70 s COOH
3.12 2H t 7 SCH2CH2CN
2.88 2H t 7 SCH2CH2CN
2.50 2H s CH2COOH
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Scheme 20.  Synthesis of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’-carboxy-
methylthio)tetrathiafulvalene (33) via tetrathiafulvalene-2,3,6,7-tetrathiolate
(9), from 2,3,6,7-tetrakis(2’-cyanoethylthio)tetrathiafulvalene (12) and
iodoacetic acid.
S
S S
S
NC
NC
S
SS
S
CN
CN
S
S
S
S
S
S
S
S
12
HOOCCH2S
CNCH2CH2S S
S SCH2COOH
SCH2CH2CNS
S
NaOMe/MeOH
30 min
ICH2COOH
12 h
33
9
41
B.III.  Synthesis of 1,3-Dithiole-2-thione-4,5-dithiolate (DMIT)-Carbo-
hydrate Derivatives
The synthesis of different DMIT-carbohydrate derivatives (DMIT = 1,3-dithiole-
2-thione-4,5-dithiolate or dimercaptoisotrithione) was performed to come to
know the structure-related activity relationship between the DMIT- and TTF-
carbohydrate derivatives using the MTT assay.
Two methods were employed for the formation of 1,3-dithiole-2-thione-4,5-
dithiolate (DMIT) (4).  Method A made use of the zinc complex 8, suspended
either in acetone, DMF or acetonitrile with the carbohydrate, and heated under
reflux (120°C)[54]. Method B proceeded by the deprotection of 10 by a strong
base [56] using either DMF or CH3CN as solvent and adding finally the sugar
(Scheme 21).
Scheme 21.  Different pathways for the formation of 1,3-dithiole-2-thione-4,5-
dithiolate (DMIT) (4) using bis(tetraethylammonium)bis(1,3-dithiole-2-thione-
4,5-dithiolato)zincate (8) or 4,5-bis(2’-cyanoethylthio)-1,3-dithiole-2-thione
(10).
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Being a bidentate nucleophile, 4 can react with double and multiple
electrophilic species in a number of ways.  The course of the reaction depends
on the conditions, the nature of the electrophilic sites or the geometry of the
electrophile [1].
In the experiment, the DMIT-derivatives were synthesized by reacting 4 with
the functionalized glucose 22, 25 and 26, ICH2CH2OH, and ICH2COOH.
B.III.1.  Synthesis of 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a -D-gluco-
pyranosyl)-1,3-dithiole-2-thione (34)
Reaction of 25 yielded via methods A and B the product 4,5-bis(1’,2’,3’,4’-tetra-
O-acetyl-6’-thio-a-D-glucopyranosyl)1,3-dithiole-2-thione (34) in 50-60% yield.
(Scheme 22).  34 forms yellow needle with a melting point of 182.6° – 184 °C
and [ ]25Da  = +147.6 (c = 0.05, DCM).
The structure of 34 was established through IR, MS, 1H and 13C NMR
spectroscopy and elemental analysis.
The infrared spectrum gives the following structural information:  carbonyl
group (~1750 cm-1, C=O stretching), and olefinic carbons (2928 cm1-, C-H
stretching, 1667 cm-1 and 1420 cm-1 C=C stretching).  The signal in the mass
spectrum at m/z 858 is probably due to the molecular ion.  The fragment m/z
526.8 corresponds to [M+ - (C14H19O9]] (C14H19O9 = carbohydrate component),
while m/z 196 corresponds to [M+ - 2(C14H19O9)].  Therefore the attachment of
two carbohydrate moieties in the molecule and the absence of the ethylcyano
leaving group is suggested.
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Figure 16.  FAB-MS spectrum of 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-
glucopyranosyl)1,3-dithiole-2-thione (34).  Interpretation of the important
fragments: (matrix NBA at T=50°C) m/z:  859 [M+H+], 858 [M], 798.9 [M-OAc],
738.9 [M-2(OAc)], 527 [M-C14H19O9] (C14H19O9 = carbohydrate component),
306.8 [matrix], 195.3 [M- C14H19O9].
Figure 17.  IR spectrum of 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-
glucopyranosyl)1,3-dithiole-2-thione (34) recorded in KBr.  Interpretation of the
important bands (cm-1):  1747, C=O;  1200-1000, C-O; 2928, 1667, 1420, C=C.
The 13C spectrum gave the usual resonance for the gluco moiety, but C-6’
resonates at higher field (d = 36.93 ppm) indicating the attachment to a thiol
group.  The appearance of a new signal at d =137.31 ppm illustrates the
presence of an olefinic carbon due to the DMIT component of the molecule.
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The 1H NMR spectrum, integrated only half the number of hydrogen atoms
which can be attributed to the compound being symmetrical. The conformation
adopted by the pyranoside ring in 34 is predominantly 1C4 due to equatorial-
equatorial relationship between H-1’ and H-2’ (J = 3.6 Hz).  Vicinal gauche
protons with dihedral angles of ~60° have smaller J values between 1-4 Hz.
Table 10.  13C chemical shifts of 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-
glucopyranosyl)-1,3-dithiole-2-thione (34).
Carbon chemical shift (d ppm) Assignment
169.65, 169.58, 169.37, 168.82 COOCH3
137.31 C=C
88.03 C-1’
70.57 C-2’
69.86 C-3’
69.01 C-4’
68.70 C-5’
36.93 C-6’H2S
20.58, 20.47, 20.32, 20.25 COOCH3
Table 11.  1H NMR chemical shifts of 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-
D-glucopyranosyl)-1,3-dithiole-2-thione (34).
Proton
chemical
shift (d ppm)
Integration Multiplicity Coupling
constant, J
(Hz)
Assignment
6.33 1H d 3.6 H-1’
5.49 1H t 10 H-3’
5.11 1H dd 3.6, 10 H-2’
5.03 1H t 10 H-4’
4.16-4.08 1H m H-5’
3.15 1H dd 3, 14 H-6’
3.00 1H dd 7, 14 H-6’’
2.33 3H s CH3
2.27 3H s CH3
2.06 3H s CH3
2.03 3H s CH3
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Scheme 22.  Synthesis of 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-gluco-
pyranosyl)-1,3-dithiole-2-thione (34) from bis(tetraethylammonium)-bis(1,3-
dithiole-2-thione-4,5-dithiolato)zincate (8) or 4,5-bis(2’-cyanoethylthio)-1,3-
dithiole-2-thione (10).
B.III.2.  Synthesis of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-O-acetyl-1’-
thio-b-D-glucopyranosyl)1,3-dithiole-2-thione (35)
Upon using method A for the synthesis of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-
tetra-O-acetyl-1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35), the 1,3-
dithiole-2-thione-4,5-dithiolate (DMIT) (4) formed acted as a nucleophile when
reacted with acetyl-protected glucosyl bromide 22 in a Koenig-Knorr type
reaction.  This resulted in the formation of a light yellow needles of 35 in 60 %
yield melting point 178.1°-179.3ºC, and [ ]25Da  = +101.88 (c = 0.07, DCM).  The
infrared spectrum gave the following structural information: carbonyl group
(1750 cm-1, C=O stretching, 1200 cm-1 C-O stretching), nitrile group (2250 cm-
1, CºN stretching), olefinic carbon (2951 cm1- C-H stretching, 1638 cm1- and
1433 cm1-, C=C stretching).  The signal in the mass spectrum at m/z 582 is
probably caused by [M+ + H].  The last signal in the MS-FAB spectrum at m/z
604 can be assigned to [M + 23], while the fragment at m/z 331 (C14H19O9 =
carbohydrate component) implies the presence of the carbohydrate moiety.
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These data suggest the attachment of one carbohydrate residue and the
ethylcyano group in the molecule.
The 13C spectrum of the compound showed the usual glucose moiety
resonances, but at higher field a resonance for the anomeric carbon at d =
82.91 ppm is found.  The new signals at d = 31.68 and d = 18.12 ppm are
indicative for the presence of SCH2CH2CN and SCH2CH2CN residues,
respectively, and at d = 118.82 ppm for the olefinic carbon.  These data confirm
the attachment of the carbohydrate moiety to the DMIT unit.  The conformation
of the carbohydrate residue was defined by the 1H NMR shift of the anomeric
proton.  The anomeric proton peak has moved significantly upfield and J1,2 is
also large (8 Hz) indicating a b configuration at the anomeric carbon.  The
glucose moiety in 35 adopts the 4C1 as predominant conformation due to the
diaxial relationship between H-1’ and H-2’ ( J = 8 Hz). This high coupling
constant is consistent with protons that are trans diaxial with a ~180º dihedral
angle.
Scheme 23.  Synthesis of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-O-acetyl-1’-
thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35) from bis(tetraethyl-
ammonium)bis(1,3-dithiole-2-thione-4,5-dithiolato)zincate (8) and 4,5-bis(2’-
cyanoethylthio)-1,3-dithiole-2-thione (10).
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Figure 18.  FAB-MS spectrum of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-O-
acetyl-1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35) .  Interpretation of
the important fragments:  (matrix NBA at T=50°C.) m/z= 604 [M+Na], 582 [M +
H+], 385.1 [M+H+-C3S5] (C3S5 = DMIT component), 331.2 [M+H+-C14H19O9],
(C14H19O9 = carbohydrate component).
Figure 19.  IR spectrum of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-O-acetyl-1’-
thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35) recorded in KBr.
Interpretation of the important bands (cm-1): 1750, C=O;  1200, C-O;  2250,
CºN; 2951, C-H; 1638 and 1433, C=C.
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Table 12.  13C NMR chemical shifts of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-
O-acetyl-1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35).
Carbon chemical shift (d ppm) Assignment
169.912, 169.503, 169.261 CH3COO
118.811 C=C
82.910 C-1’
74.824 C-2’
72.585 C-3’
69.227 C-4’
67.624 C-5’
61.713 C-6’
31.684 SCH2CH2CN
20.712, 20.425, 20.377, 20.247 CH3COO
18.123 SCH2CH2CN
Table 13.  1H NMR chemical shifts of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-
O-acetyl-1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35).
Proton
chemical
shift (d ppm)
Integration Multiplicity Coupling
constant, J
(Hz)
Assignment
5.23 1H t 9.4 H-3’
5.11 1H t 9.4 H-4’
5.00 1H dd 7.9, 9.4 H-2’
4.43 1H d 7.9 H-1’
4.29 1H dd 4, 12 H-6’
4.21 1H dd 4, 12 H-6’’
3.72-3.65 1H m H-5’
3.25 2H t 7 SCH2CH2CN
2.93 2H t 7 SCH2CH2CN
2.18 3H s CH3COO
2.15 3H s CH3COO
2.13 3H s CH3COO
2.09 3H s CH3COO
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B.III.3.  Synthesis of 4,5-bis(6’-thio-D-glucopyranosyl)-1,3-dithiole-2-
thione (36) and 4-(2’’-cyanoethylthio)-5-(1’-thio-b-D-glucopyranosyl)-1,3-
dithiole-2-thione (37)
The synthesis of of 4,5-bis(6’-thio-D-glucopyranosyl)-1,3-dithiole-2-thione (36)
and 4-(2’’-cyanoethylthio)-5-(1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione
(37) involved the simple hydrolysis of 34 and 35 using catalytic amounts of
NaOMe in methanol.  Not much information was obtained from the 1H
spectrum of 36 and 37 in D2O because of large water peaks at d 4.60.
However, the infrared spectrum showed the presence of a big broad band at
~3500 cm1- due to OH group and the absence of carbonyl functionality at 1750
cm1-. The m/z 413 peak in the mass spectrum corresponds to the expected
molecular mass of 37.  However, the mass spectrum of 36 did not give the
expected molecular mass.  Instead a peak at m/z 530 may be caused by a
completely protonated product and a fragment at m/z 219 may be assigned to
[DMIT + 23].  Therefore, the recovered water-soluble brown thick oily product
was immediately used for the MTT assay.
B.III.4  Reaction of 1,3-dithiole-2-thione-4,5-dithiolate (DMIT) with 3,4,6-
tri-O-acetyl-D-glucal (26).
An attempt was made to react 1,3-dithiole-2-thione-4,5-dithiolate (DMIT) (4)
with 3,4,6-tri-O-acetyl-D-glucal (26).  26 contains a double bond between
positions 1 and 2.  The thiol group is capable to add to double bonds [58].
However, based on the results, a very polar product was obtained from method
A, which turned out to be just the deprotected 26.  The reaction using method
B produced negative results.
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Scheme 24.  Synthesis of of of 4,5-bis(6’-thio-D-glucopyranosyl)-1,3-dithiole-2-
thione (36) from 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-glucopyranosyl)-
1,3-dithiole-2-thione (34).
Scheme 25.  Synthesis of 4-(2’’-cyanoethylthio)-5-(1’-thio-b-D-glucopyranosyl)-
1,3-dithiole-2-thione (37) from 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-O-
acetyl-1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35).
Scheme 26.  Reaction of 3,4,6-tri-O-acetyl-D-glucal (26) with bis-
(tetraethylammonium)-bis(1,3-dithiole-2-thione-4,5-dithiolato)zincate (8) or
4,5-bis(2’-cyanoethylthio)-1,3-dithiole-2-thione (10).
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B.III.5.  Synthesis of 4,5-bis(2’-hydroxyethylthio)-1,3-dithiole-2-thione
(38)
The synthesis of the compounds 4,5-bis(2’-hydroxyethylthio)-1,3-dithiole-2-
thione (38) and 4,5-bis(2’-carboxymethylthio)-1,3-dithiole-2-thione (39) was
performed, to produce a non-carbohydrate-containing, water-soluble, DMIT-
derivative to be used in the biological assay.
Only method A was used in the synthesis for 4,5-bis(hydroxyethylthio)-1,3-
dithiole-2-thione (38), yielding 67% of yellow-green crystals with a melting
point of 73.1º-75.7ºC.  The FAB-MS spectrum gave m/z 287 [M +1] which is
the expected molecular mass of the compound.  Additional information from
the 13C and 1H NMR spectra confirmed the structure of the compound.
Table 14.  13C NMR chemical shifts of 4,5-bis(2’-hydroxyethylthio)-1,3-dithiole-
2-thione (38).
Carbon chemical shift (d ppm) Assignment
206.62 C=S
136.11 C=C
60.07 SCH2CH2OH
38.64 SCH2CH2OH
Table 15.  1H NMR chemical shifts of 4,5-bis(2’-hydroxyethylthio)-1,3-dithiole-
2-thione (38).
Proton
chemical
shift (d  ppm)
Integration Multiplicity Coupling
constant,
J (Hz)
Assignment
5.05 1H t 5.5 CH2OH
3.66 2H dd 6.3, 12 SCH2CH2OH
3.08 2H dd 6.3, 12 SCH2CH2OH
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Scheme 27.  Synthesis of 4,5-bis(2’-hydroxyethylthio)-1,3-dithiole-2-thione
(38) from bis(tetraethylammonium)bis(1,3-dithiole-2-thione-4,5-dithiolato)-
zincate (8).
B.III.6.  Synthesis of 4,5-bis(2’-carboxymethylthio)-1,3-dithiole-2-thione
(39)
4,5-bis(2’-carboxymethylthio)-1,3-dithiole-2-thione (39) was prepared following
Hoyer et. al. [42]. Bis(tetraethylammonium)bis(1,3-dithiole-2-thione-4,5-
dithiolato)zincate (8) in acetone is mixed with ICH2COOH , NaOH and H2O and
heated under reflux until the disappearance of the red color of 8.  Acetone was
removed in vacuo, HCl was added with cooling, forming yellow crystals.  The
product was recrystallized by dissolving the crystals in dilute NH3 and slow
addition of HCl (50%). Yellow crystals of 39, with a melting point of 172º-174ºC
(lit. [42] 171°-173°C) and m/z= 315 [M+1] and 337 [M+23] peaks in the FAB-
MS were isolated.  The 13C and 1H NMR spectral data obtained are similar to
the literature [42].
Scheme 28.  Synthesis of 4,5-bis(2’-carboxymethylthio)-1,3-dithiole-2-thione
(39) from bis(tetraethylammonium)-bis(1,3-dithiole-2-thione-4,5-dithiolato)zin-
cate (8).
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B.IV.  3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT)
Assay
The biological activity of the synthesized derivatives was tested on human
neuroblastoma cell lines SK-N-LO and SK-N-SH using the MTT assay, with
doxorubicin as a standard.
MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (5), is a
yellow tetrazolium salt which can be transformed into the purple coloured
formazan (6) crystals, by metabolic active cells.  The greater the number of vital
mitochondria the more MTT will be transformed into formazan.  The formazans
are difficult to be dissolved.  It is first dissolved prior to measurement in
isopropanol and the released, dissolved formazan reagent is measured
spectrophotometrically with an ELISA reader.  Since reduction of MTT can only
occur in metabolically active cells, the level of activity is a measure of the
viability of the cells.
The water-soluble derivatives were weighed and dissolved in an appropriate
amount of sterile and deionized water to prepare the stock solution.  The
solution was then stored at –20ºC for further use.
There were four independent experiments, each was performed four fold.  The
first trial was performed using the freshly prepared solution of the synthesized
derivatives.  The second trial was done from a sample that was stored for 4
days at –20°C, the third one after 8 days of sample storage, and the fourth one
after 12 days of sample storage.  Figures 20-23 show the effect of different
concentrations (0.030, 0.300, 1.50, 3.00 µM/mL) of the test samples against
the neuroblastoma cell lines.  The % mortality of the cells is ~ 95.0 - 99.0% at
the highest concentration used which was 3.00 µM/mL. While at the lowest
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concentration used, 0.030 µM/mL, there were trials wherein the number of the
cells was large compared to the control. This can be explained by the resistance
developed by the cells at a very small concentration of the sample, a well
known phenomenon also observed in experiments with conventional cytotoxic
drugs.
The results were compared to the doxorubicin (7) standard, which is normally
employed in antitumor activity testing.  This standard was chosen, based on its
structure, and the possibility that the TTF could undergo a mechanism similar
to 7, namely intercalation and redox active mechanisms, upon its reaction with
the tumor cells.  At a concentration of 3.00 µM/mL the TTF-carbohydrate
derivatives showed a tumor cell survival percentage between 2-10% which is
comparable to 7 which at a concentration of  3.00 µM/mL showed a 17.5 %
tumor cell survival .  However, based on the experiment LD50 for TTF-
carbohydrate conjugate has a range between ~ 0.070 – 2.00 µM/mL, while
doxorubicin has an LD 50 ~ 0.10 µM/mL (Table 16).
The cytotoxicity of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-glucopyranosyl)-
tetrathiafulvalene (30) and 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-gluco-
pyranosyl)tetrathiafulvalene (31), on both neuroblastoma cell lines tested, was
dose dependent and was compared to doxorubicin.  As shown in the figures,
there is a significant difference in the sensitivity of SK-N-LO and SK-N-SH
against 30 and 31.  At the moment it can only be speculated about the reason
of this effect.  It is known that SK-N-LO cells lack catalase activity, in contrast
to SK-N-SH cells, and therefore, these cells are more reactive against reactive
oxygen species (ROS).  It may be that part of the effects of 30 and 31 is caused
by the generation of  ROS.  However, other mechanisms explaining the
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cytotoxicity of 30 and 31 are possible.  The structural similarity to doxorubicin
( both are planar molecules) may allow intercalation in the DNA-disturbing
replication.  Furthermore, it would be interesting to investigate the influence of
these substances on the process of apoptosis.  Unfortunately, not enough
substances were available to study these processes in more detail.
Nevertheless, the results obtained by the MTT test indicate that both
substances have an effect on tumor cells in a concentration range not highly
different from the well known and effective antitumor drug doxorubicin.
 The assay was also performed on the 1,3-dithiole-2-thione-4,5-dithiolate
(DMIT)-carbohydrate derivatives 4,5-bis(6’-thio-D-glucopyranosyl)-1,3-dithiole-
2-thione (36) and 4-(2’’-cyanoethylthio)-5-(1’-thio-b-D-glucopyranosyl)-1,3-
dithiole-2-thione (37).  The samples did not exhibit significant cytotoxicity
against SK-N-LO and SK-N-SH neuroblastoma cells.  (Tables 17-20).
The MTT assay was not performed on compounds 4,5-bis(2’-hydroxyethylthio)-
1,3-dithiole-2-thione (38), and 4,5-bis(2’-carboxymethylthio)-1,3-dithiole 2-
thione (39), because these are only slightly soluble in water.
On the other hand, the following compounds are water-insoluble such that the
MTT assay was not also performed:  2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-arabino-
pyranosyl)tetrathiafulvalene (27), 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-
tetra -O-acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28), 2,6-bis(2’’-
cyano-ethylthio)-3,7-bis(2’,3’,4’,6’-tetra-O-acetyl-1’-thio-b-D-glucopyranosyl)-
tetrathiafulvalene (29), 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-glucopy-
ranosyl)-1,3-dithiole-2-thione (34), and 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-
O-acetyl-1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35).
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Table 16.  LD50 of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-glucopyranosyl)-
tetrathiafulvalene (30) and 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-gluco-
pyranosyl)tetrathiafulvalene (31) on SK-N-LO and SK-N-SH neuroblastoma cell
lines.
Cell
line
SK- N- SH SK- N- LO
Trial 1 2 3 4 1 2 3 4
LD 50
31
(µM/mL)
0.0773 0.0765 0.199 0.523 0.143 0.225 1.930 0.969
LD 50
30
(µM/mL)
0.152 0.300 0.119 0.469 0.0286 0.545 0.756 0.800
Table 17.  Effect of different concentrations of 4,5-bis(6’-thio-D-
glucopyranosyl)-1,3-dithiole-2-thione (36)  on % of survival of SK-N-SH
neuroblastoma cells. The absorbance of the control was taken as 100% survival
and the values given are the ratios between the absorbance of the test
substance and the control.  The average from 4 replicates in 3 independent
trials and the +/-  standard deviation are given.  First trial was performed
using the freshly prepared solution.  The second trial was performed in a
sample that was stored for 4 days.  Third trial was done after 8 days of sample
storage.
Concentration
µM/mL
Trial 1 Trial 2 Trial 3
3.00 2.34 ± 0.30 58.00 ± 5.1 58.51 ± 4.5
1.50 3.00 ± 0.40 93.00 ± 2.4 94.00 ± 1.5
0.30 97.00 ± 6.4 88.00 ± 0.7 104.00 ± 0.9
0.030 98.30 ± 2.7 100.00 ± 1.7 104.00 ± 1.9
57
Table 18.  Effect of different concentrations of 4-(2’’-cyanoethylthio)-5-(1’-thio-
b-D-glucopyranosyl)-1,3-dithiole-2-thione (37) on % of survival of SK-N-SH
neuro-blastoma cells. The absorbance of the control was taken as 100%
survival and the values given are the ratios between the absorbance of the test
substance and the control.  The average from 4 replicates in 3 independent
trials and the +/-  standard deviation are given.  First trial was performed
using the freshly prepared solution.  The second trial was performed in a
sample that was stored for 4 days.  Third trial was done after 8 days of sample
storage.
Concentration
µM/mL
Trial 1 Trial 2 Trial 3
3.00 24.50 ± 0.8 50.00 ± 0.7 69.70 ± 2.7
1.50 81.50 ± 2.3 49.50 ± 2.2 89.60 ± 2.6
0.30 98.50 ± 1.1 99.00 ± 1.0 93.00 ± 4.1
0.030 104.00 ± 0.9 117.00 ± 4.5 94.30 ± 4.4
Table 19.  Effect of different concentrations of 4,5-bis(6’-thio-D-
glucopyranosyl)-1,3-dithiole-2-thione (36) on % of survival of SK-N-LO
neuroblastoma cells. The absorbance of the control was taken as 100% survival
and the values given are the ratios between the absorbance of the test
substance and the control.  The average from 4 replicates in 3 independent
trials and the +/-  standard deviation are given.  First trial was performed
using the freshly prepared solution.  The second trial was performed in a
sample that was stored for 4 days.  Third trial was done after 8 days of sample
storage.
Concentration
µM/mL
Trial 1 Trial 2 Trial 3
3.00 12.43 ± 0.6 25.60 ± 0.6 24.90 ± 1.6
1.50 71.56 ± 1.3 120.0 ± 1.5 191.0 ± 5.4
0.30 113.00 ± 1.3 120.0 ± 1.5 203.0 ± 3.3
0.030 114.00 ± 2.9 175.0 ± 5.4 179.4 ± 1.1
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Table 20.  Effect of different concentrations of 4-(2’’-cyanoethylthio)-5-(1’-thio-
b-D-glucopyranosyl)-1,3-dithiole-2-thione (37) on % of survival of SK-N-LO
neuro-blastoma cells. The absorbance of the control was taken as 100%
survival and the values given are the ratios between the absorbance of the test
substance and the control.  The average from 4 replicates in 3 independent
trials and the +/-  standard deviation are given.  First trial was performed
using the freshly prepared solution.  The second trial was performed in a
sample that was stored for 4 days.  Third trial was done after 8 days of sample
storage.
Concentration
µM/mL
Trial 1 Trial 2 Trial 3
3.00 91.00 ± 6.2 93.50 ± 6.2 106.0 ± 3.1
1.50 192.0 ± 4.3 164.0 ± 4.3 107.0 ± 2.4
0.30 174.0 ± 6.8 152.0 ± 6.8 105.0 ± 6.8
0.030 132.6 ± 5.9 155.0 ± 3.9 186.3 ± 9.1
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Figure 20.  Activity of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-
glucopyrano-syl)tetrathiafulvalene (31) against SK-N-LO neuroblastoma cells.
200 mL of SK-N-LO cells were plated at 10,000 cells/well on a 96 well plate.
After 24 h incubation at 37°C (5% CO2 and 100 % humidity) 10 mL of
compound 31 at concentrations of 0.030, 0.300, 1.50, 3.00 mM/mL was added
to the wells.  After 48 h in the incubator, the cell medium was removed and
100 mL of MTT solution was added to each well.  After 3 h in the incubator, 100
mL of isopropyl alcohol was then added to each well .  After overnight shaking,
the absorbance of the colour in each well was measured by a microplate reader
( MR 700) at wavelengths of 550 and 630 nm.  The absorbance of the control
was taken as 100% survival and the values given are the ratios between the
absorbance of the test substance and the control.  The average from 4
replicates in 4* independent trials and the +/-  standard deviation was plotted.
*First trial was performed using the freshly prepared solution.
 Second trial was performed in a sample that was stored for 4 days.
 Third trial was done after 8 days of sample storage.
 Fourth trial was performed after 12 days of sample storage.
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Figure 21.  Activity of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-glucopyrano-
syl)tetrathiafulvalene (30) against SK-N-LO neuroblastoma cells.  200 mL of SK-
N-LO cells were plated at 10,000 cells/well on a 96 well plate.  After 24 h
incubation at 37°C (5% CO2 and 100 % humidity) 10 mL of compound 30 at
concentrations of 0.030, 0.300, 1.50, 3.00 mM/mL was added to the wells.
After 48 h in the incubator, the cell medium was removed and 100 mL of MTT
solution was added to each well.  After 3 h in the incubator, 100 mL of isopropyl
alcohol was then added to each well .  After overnight shaking,  the absorbance
of the colour in each well was measured by a microplate reader ( MR 700) at
wavelengths of 550 and 630 nm.  The absorbance of the control was taken as
100% survival and the values given are the ratios between the absorbance of
the test substance and the control.  The average from 4 replicates in 4*
independent trials and the +/-  standard deviation was plotted.
*First trial was performed using the freshly prepared solution.
 Second trial was performed in a sample that was stored for 4 days.
 Third trial was done after 8 days of sample storage.
 Fourth trial was performed after 12 days of sample storage.
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Figure 22.  Activity of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-
glucopyrano-syl)tetrathiafulvalene (31) against SK-N-SH neuroblastoma cells.
200 mL of SK-N-SH cells were plated at 10,000 cells/well on a 96 well plate.
After 24 h incubation at 37°C (5% CO2 and 100 % humidity) 10 mL of
compound 31 at concentrations of 0.030, 0.300, 1.50, 3.00 mM/mL was added
to the wells.  After 48 h in the incubator, the cell medium was removed and
100 mL of MTT solution was added to each well.  After 3 h in the incubator, 100
mL of isopropyl alcohol was then added to each well .  After overnight shaking,
the absorbance of the color in each well was measured by a Microplate Reader
(MR 700) at wavelengths of 550 and 630 nm.  The absorbance of the control
was taken as 100% survival and the values given are the ratios between the
absorbance of the test substance and the control.  The average from 4
replicates in 4* independent trials and the +/-  standard deviation was plotted.
*First trial was performed using the freshly prepared solution.
 Second trial was performed in a sample that was stored for 4 days.
 Third trial was done after 8 days of sample storage.
 Fourth trial was performed after 12 days of sample storage.
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Figure 23.  Activity of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-glucopyrano-
syl)tetrathiafulvalene (30) against SK-N-SH neuroblastoma cells.  200 mL of SK-
N-SH cells were plated at 10,000 cells/well on a 96 well plate.  After 24 h
incubation at 37°C (5% CO2 and 100 % humidity) 10 mL of compound 30 at
concentrations of 0.030, 0.300, 1.50, 3.00 mM/mL was added to the wells.
After 48 h in the incubator, the cell medium was removed and 100 mL of MTT
solution was added to each well.  After 3 h in the incubator, 100 mL of isopropyl
alcohol was then added to each well .  After overnight shaking,  the absorbance
of the colour in each well was measured by a microplate reader (MR 700) at
wavelengths of 550 and 630 nm.  The absorbance of the control was taken as
100% survival and the values given are the ratios between the absorbance of
the test substance and the control.  The average from 4 replicates in 4*
independent trials and the +/-  standard deviation was plotted.
*First trial was performed using the freshly prepared solution.
 Second trial was performed in a sample that was stored for 4 days.
 Third trial was done after 8 days of sample storage.
 Fourth trial was performed after 12 days of sample storage.
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Experimental Part
Standard Experimental Procedures
All reactions were performed under an inert atmosphere (nitrogen) with dry
reagents and oven-dried glasswares.  The reactions were monitored by thin la-
yer chromatography, carried out on 0.25 mm silica gel plates (60 F-254, Merck,
Darmstadt, Germany).  Plates were visualized by iodine, uv light( where
appropriate) or sprayed with an orcinol/H2SO4/FeCl3 solution and heated to
develop coloration.  Preparative thin layer chromatography was performed on
0.5x20x20 cm silica gel plates 860 F-254, Merck, Darmstadt, Germany).
1H and 13C NMR spectra were recorded on a Bruker AC 250 (1H NMR:  250
MHz, 13C NMR:  63 MHz) or a Bruker WM 400-spectrometer (1H NMR:  400
MHz, 13C NMR:  100 MHz) either in CDCl3 , DMSO-d6, acetone-d6 or MeOH-d4
with internal TMS.  The chemical shifts are reported in parts per million (ppm)
on the d scale from TMS as an internal standard.  Elemental analyses were
performed on a Perkin-Elmer elemental analyser, model 240.  The EI, FD and
FAB mass spectra were recorded on a Finnigan MAT 312 mass spectrometer
connected to a PDO 11/34 (DEC) computer system.  Optical rotations were
obtained with an LEP AZ polarimeter (Zeiss, Jena) at 546 nm.
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C.I.  Syntheses of Starting Materials
C.I.1.  Synthesis of 2,3,6,7-tetrakis(2’-cyanoethylthio)tetrathiafulvalene
(12)
C.I.1.1  Bis(tetraethylammonium)-bis(1,3-dithiole-2-thione-4,5-dithiolato)-
zincate (8)
Finely shaved sodium metal  (46 g, 2 mol) was added to anhydrous CS2 (350
mL, 5.8 mol) and cooled in an ice bath (0°-5°C).  Dry DMF (400 mL) was added
slowly over a period of six hours.  After stirring overnight, the solution was
cooled in an ice bath, and methanol (100 mL) was added slowly to get rid of
unreacted sodium.  After diluting the solution with 1.5 MeOH/H2O (2.5 L), it
was transferred into an Erlenmeyer flask.  ZnCl2 (40g) in ammonia solution
(750 mL) and diluted with methanol (750 mL) were added to the flask.  To the
resulting solution, Et4Br (66 g) in distilled H2O (500 mL) was slowly added over
a period of 4 hours and stirrred overnight.  The solution was filtered using a
large sintered glass funnel.  The solid was washed with distilled H2O,
isopropanol until the filtrate was clear and lastly with diethylether (500 mL).
After drying 8 was obtained as deep red precipitate (99.10 g, 55%); m.p.
202.4°-205.0° C, ref.  [42]:  200-205°C. FAB–MS:  m/z = 719.0 [M+ + 1].
C22H40N2S10Zn ( 718.6)
Calculated: C  36.77% H  5.56% N  3.89% S  44.53%
Found: C  31.89% H  4.23% N  3.57% S  44.10%
C.I.1.2.  4,5-Bis(2’-cyanoethylthio)-1,3-dithiole-2-thione (10)
To a solution of  8 (2.57 g, 3.57 mmole) in MeCN (50 mL) was added 3-
bromopropionitrile (2.42 g, 18.0 mmol) and the mixture was refluxed for 2
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hours.  The resulting solution was cooled to room temperature and the
precipitated salt was filtered.  The brown-yellow filtrate was concentrated in
vacuo, the resulting product was dissolved in CH2Cl2 (50 mL) , washed with
water (4 x 100 mL) , dried (Na2SO4) and the solvent removed in vacuo.
Recrystallization of the product from toluene/petroleum ether (bp 100-140°C)
gave 10 as long yellow needles; yield 2.26 g (70%); mp 84.8-86.5°C, ref. [56]:
83°C.Rf 0.737 (DCM/toluene/hexane/acetone/; 1/1/1/1) FAB–MS:  m/z = 305
[M+ + 1].  C9H8N2S5 ( 304.5)
Calculated: C  35.53% H  2.63% N  9.21% S  52.71%
Found: C  35.59% H  2.30% N  9.15% S  54.00%
C.I.1.3.  4,5-Bis(2’-cyanoethylthio)-1,3-dithiol-2-one (11)
A mixture of 10 (1.5 g, 4.93 mmol) in DCM/AcOH (3:1, 50 mL) and Hg(OAc)2
(4.11 g, 13.14 mmol)  was stirred under N2 at r.t. for 16 h.  The resulting white
precipitate was filtered using membrane filter and washed thoroughly with
DCM.  The combined organic phases were refluxed with  activated charcoal,
cooled to room temperature, washed with saturated NaHCO3 solution (3 x 100
mL), water (100 mL), dried (Na2SO4) and concentrated in vacuo affording 11 as
large pale yellow needles; yield :1.46 g, 99%, mp 64-65°C, ref. [56]:  64-65°C.
FAB–MS:  m/z = 289 [M+ + 1].  C9H8N2S4O:  (288.44)
Calculated: C  37.50% H  2.77% N  9.72% S  44.44%
Found: C  37.62% H  2.26% N  9.79% S  44.78%
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C.I.1.  2,3,6,7-Tetrakis(2’-cyanoethylthio)tetrathiafulvalene (12)
11 (1.40 g, 4.85 mmol) was suspended in toluene (50 mL) and refluxed with
stirring while freshly distilled triethylphosphite (5 mL) was added.  After about
30 min a red-orange precipitate starts to form, the red solution was stirred for
an additional 1 h at reflux and then allowed to cool at room temperature.
MeOH (25 mL) was added, the product was filtered, washed with MeOH (3 x 25
mL) and dried in vacuo, to give 12 as intense red-orange crystals; yield  0.9 g
(66%); mp 186.9-188.4°C, ref.[56]:  209-210°C.  FAB–MS:  m/z = 545 [M+ + 1]
C18H16N4S8:  (544.0)
Calculated: C  39.71% H  2.93% N  10.29% S  47.06%
Found: C  39.71% H  2.40% N  10.33% S  45.19%
C.I.2.  Synthesis of benzyl 2,3-anhydro-b -L-ribopyranoside (18)
C.I.2.1.  Benzyl ß-L-arabinopyranoside (14)
14 was prepared from L-arabinose (13) 50 g (0.33 mol) and freshly distilled
benzyl alcohol ( 250 mL) and absolute ether (1000 mL) as described in [48].
Yield 73 g (91%); m.p. 171-173°C (ethanol/water), ref. [48] :  168°-171° C
(ethanol); [ ]25°CDa = +210° (c = 1, H2O) ref [48]:  +206° (c = 3, H2O).
C12H16O5 (240.23)
Calculated: C 59.99% H 6.70%
Found: C 59.55% H 6.50%
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C.I.2.2.  Benzyl 3,4-O-isopropylidene-b-L-arabinopyranoside (15)
15 was prepared from 14 (72 g, 0.30 mol), 2,2-dimethoxypropane (500 mL) and
p-toluenesulfonic acid (1 g) in acetone (500 mL).  The resultant syrup 15 was
used without further purification for the next step.  Yield 53 g (89%).
C.I.2.3.  Benzyl 3,4-O-isopropylidene-2-O-p-tolylsulfonyl-b -L-arabinopyra-
noside (16)
16 was prepared from 15 (75 g, 0.27 mol), dissolved in pyridine (500 mL) and
p-toluenesulfonyl chloride (199 g) as described in [48].  Yield 107.3 g (92%);
m.p. 93-95°C (ethanol/water), ref. [48]: 93°- 94° C (ethanol/water); [ ]25°CDa =
+183° (c = 1, CHCl3), ref[48]: (c = 1, CHCl3).  C22H26O7S:  (434.47)
Calculated: C  60.81% H  6.02% S  7.37%
Found C  60.61% H  6.06% S  7.15%
C.I.2.4.  Benzyl 2-O-p-tolylsulfonyl-b-L-arabinopyranoside (17)
17 was prepared from 16 (107 g, 0.24 mol) and 90 % acetic acid  (100 mL) as
described in the ref [48].  Yield 88.7 g (91%); m.p. 119°-120°C
(methanol/water), ref. [48]:  118°-120°C (methanol/water); [ ]25°CDa = +128 (c= 1,
CHCl3), ref. [48]:  +134 (c= 1, CHCl3).  C19H22O7S:  (394.41)
Calculated: C  57.81% H  4.61% S  8.12 %
Found C  57.71% H  5.50% S  8.05%
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C.I.2.5.  Benzyl 2,3-anhydro-b -L-ribopyranoside (18)
18 was prepared from 17 (88 g, 0.22 mol), methanol (950 mL) and sodium (7.1
g, 0.30 mol).  Yield 28.7  g  (92.6%);   m.p. 76°-77° C (EE), ref. [48]:  76°-77° C
(EE); [ ]25°CDa =  -3 (c= 1, EE); [ ]
25°C
D
a = -11 (c = 1, EE).
C12H14O4 (222.22)
Calculated C  64.86% H  6.34%
Found C  64.32% H  6.32%
C.I.2.  Benzyl 2,3-anhydro-4-O-triflyl-b -L-ribopyranoside (19)
19 was prepared from 18 (2.22 g, 10 mmol), CH2Cl2 ( 75 mL), pyridine (2 mL)
and trifluromethanesulfonic anhydride (1.8 mL, 10.97 mmol), synthesized  as
described in ref. [48]. Yield 3.13 g (90%); m.p. 83°-84° C (ethanol), ref. [48]:
82°-83° C (ethanol); [ ]25°CDa = +16° (c= 1, CHCl3), ref. [48]: [[ ]
25°C
D
a = +16° (c= 1,
CHCl3).  C13H13F3O6S:  (354.29)
Calculated C  44.07% H  3.69% S  9.04%
Found C  43.85% H  3.60% S  9.25%
C.I.3.  Synthesis of 2,3,4,6-tetra-O-acetyl-a -D-glucopyranosylbromide (22)
[51]
C.I.3.1.  1,2,3,4,6-Penta-O-acetyl-a-D-glycopyranoside (21)
Sodium acetate  (5.5 g) in acetic anhydride (100 ml) were heated until boiling.
D-(+)-glucose (20) (10 g, 55.5 mmole) were added slowly and remained heated
until the solution became clear.  After cooling to room temperature, the
solution was poured in crushed ice (100 g) and allowed to stand for 3 hours.
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The resulting precipitate was filtered, washed with water and dried in vacuo.
Recrystallization in ethanol (95%) gave 21 ( 18.2g,  83.9 %) mp 136-137°C, ref
[51]:  128°-130°C.  FAB–MS:  m/z = 391.  C16H22O11:  (390.0)
Calculated: C  49.23% H  5.64%
Found: C  49.11% H  5.26%
C.I.3.  2,3,4,6-Tetra-O-acetyl-a-D-glucopyranosyl bromide (22)
To 21 (2.3 g, 5.8 mmole) was added 45% HBr/HOAc (15 ml) and stirred for 3
hours.  Reaction was monitored by TLC.  Solution was diluted with
dichloromethane and added to crushed ice (~200 g) Organic phase was
separated washed with NaHCO3 (2 x 200 ml) , dried with Na2SO4, filtered and
solvent evaporated in vacuo.  The product was precipitated from the resulting
liquid by adding diethyl ether (15 ml) and dropwise addition of petroleum ether
with trituration.  The product was obtained as white precipitate (2.176 g,
89.5%); mp 86°-87°C, ref [51] 87°-88°C Rf= 0.7 (acetone/DCM/
hexane/toluene). FAB–MS:  m/z = 412.  C14H19O9Br:  (411.0)
Calculated: C  40.88% H  4.62%
Found: C  40.44% H  3.55%
C.I.4.  Synthesis of 1,2,3,4-tetra-O-acetyl-6-deoxy-6-iodo-a-D-glucopy-
ranoside (25) [52]
C.I.4.1.  Methyl 2,3,4-tri-O-acetyl-6-deoxy-6-iodo-a-D-glucopyranoside (24)
A mixture of methyl-a-D-glucopyranoside (23) (2.0 g, 10.3 mmol),
triphenylphosphine (4.05 g, 15.5 mmol), imidazole (2.10 g, 30.9 mmol) and
iodine (3.9 g, 15.5 mmol) in toluene (200 mL) was vigorously stirred at 70°C for
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2.5 hours.  Heating was stopped and resulting mixture was stirred for another
15 hours.  After water (200 mL) was added, the mixture was vigorously stirred
for 20 minutes and transferred to a separatory funnel.  The organic phase was
extracted with water until no product is left in the toluene layer.  The combined
aqueous phase was concentrated in vacuo.  Acetic anhydride (40 mL) and
pyridine (52 mL) were added and the solution was stirred overnight.  After
removing the solvent in vacuo, the residue is dissolved  in toluene, washed with
water, dried with Na2SO4, filtered, and concentrated in vacuo.  Recrystallization
in absolute ethanol gave 24 as a white solid (3.10 g, 88%), mp 151°-152°C, ref.
[52]:  146°-147°C.   FAB–MS:  m/z =  431 [M+ + 1].  C13H19O8I:  (430.0)
Calculated: C  36.28% H  4.42%
Found: C  36.31% H  4.13%
C.I.4.  1,2,3,4-Tetra-O-acetyl-6-deoxy-6-iodo-a-D-glucopyranoside (25)
To a solution of 24 (3.28 g, 7.6 mmol), in acetic anhydride (50 mL) and glacial
acetic acid (20 mL) was slowly added conc. H2SO4 (1.6 mL).  After stirring for
24 hours, solution was poured into crushed ice (100 g).  The precipitate was
filtered and thoroughly washed with saturated NaHCO3 and distilled water.
The precipitate was dried in a dessicator under high vacuum with silica and
P2O5 for 2 hours.  Recrystallization in absolute ethanol gave 25 as white
crystals (3.0 g, 84.5%), mp 175°-176°C, ref [52]:  172°C. FAB–MS:  m/z =  459
[M+ + 1].  C14H19O9I:  (458.2)
Calculated: C  36.68% H  4.15%
Found: C  32.58% H  3.59%
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C.II.  Synthesis of Tetrathiafulvalene-Carbohydrate Conjugates
C.II.1.  2,3,6,7-Bis(benzyl 3’,4’-dithio-a -D-arabinopyranosyl)tetrathiafulva-
lene (27)
Cesium hydroxide (CsOH.H2O) (87.6  mg, 0.52 mmol) in MeOH (10 ml) was
injected 12 (63.0 mg, 0.12 mmol) in dry and degassed DMF (10 ml) under
nitrogen .  Reaction was stirred for two hours, 19 (214 mg, 0.52 mmol) in DMF
(5 ml) was added and solution stirred for 12 hours.  After removing the solvent
in vacuo, the residue was dissolved in DCM, washed with water, dried with
Na2SO4 , filtered and the solvent evaporated in vacuo.  The residue was
subjected to flash column chromatography using 10 % EtOAC/DCM as eluting
solvents affording brown oil (76 mg, 80.0% yield); Rf 0.38 (10% EtOAC/DCM);
[ ]25°CDa = +62.55 (c = 0.1 DCM);  FAB-MS m/z= 740 [M+]
Calculated: C  48.65% H  3.78% S  34.59%
Found: C  48.99% H  3.30% S  32.26%
13C (63 MHz, acetone d-6/TMS) d = 138.84 (C6H5), 128.61, 128.52, 128.40
(C6H5), 119.09 (C=C), 104.04 (C-1’), 95.20 (C-2’), 70.80 (OCH2Ph, (B), 56.16 (C-
3’), 52.23 (C-5’), 50.66 (C-4’).
1H (250 MHz, CDCl3 /TMS) d = 7.29-7.36 (5H, m, C6H5), 4.93 (1H, d, J = 12,
OCHHPh), 4.80 (1H, d, J = 12, OCHHPh), 4.61 (1H, dd, J = 8, 12, H-5’), 4.47
(1H, d, J = 7.5, H-1’), 4.18 (1H, dd, J = 4, 12, H-5’’), 3.92 (1H, ddd, J = 4, 7, 10,
H-4’), 3.65 (1H, dd, J = 5, 7.5, H-2’), 3.56 (1H, dd, J = 5, 10, H-3’).
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Figure 24.  13C NMR spectrum of 2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-arabino-
pyranosyl)tetrathiafulvalene (27).  63 MHz, acetone-d6.  See also Table 2.
Figure 25.  1H NMR spectrum of 2,3,6,7-bis(benzyl 3’,4’-dithio-a-D-arabino-
pyranosyl)tetrathiafulvalene (27).  250 MHz, CDCl3.  See also Table 3.
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C.II.2.  2,6-Bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-
a-D-glucopyranosyl)tetrathiafulvalene (28)
Cesium hydroxide (CsOH.H2O) (64.9 mg, 0.39 mmol) in MeOH (10 ml) was
injected to 12 (50.0 mg, 0.09 mmol) in dry and degassed DMF (3 ml) under
nitrogen.  Reaction was stirred for two hours, 25 (179 mg, 0.39 mmol) in DMF
(3 ml) was added and solution stirred for 28 hours.  After removing the solvent
in vacuo, the residue was dissolved in DCM, washed with water, dried with
Na2SO4 , filtered and the solvent evaporated in vacuo.  The residue was
subjected to flash column chromatography using 10 % EtOAC/DCM as eluting
solvents affording yellowish-brown oil (49 mg, 48.6% yield);  Rf 0.40 (10%
EtOAC/DCM); [ ]25°CDa = +101 (c = 0.1 DCM).  FAB-MS m/z =  1098 [M+]
Calculated: C  44.08% H  4.19% S  23.32% N  2.55%
Found: C  47.64% H  2.74% S  10.61% N  3.57%
13 C (250 MHz, CDCl3/TMS)
d = 170.23, 169.67, 169.59, 168.75, (COOCH3), 117.50, (C=C), 88.88, (C-1’),
70.76 (2C), 69.69, 69.26, (C-2’–C-5’), 37.29, (C-6’), 31.40, (SCH2CH2CN),
20.84,20.73, 20.68, 20.46, (CH3COO), 18.82, (SCH2CH2CN).
1H (250 MHz, CDCl3/TMS)
 d = 6.25, (1H, d, 4, H-1’), 5.43, (1H, t, J = 10, H-3’), 5.04, (1H, dd, J = 4, 10, H-
2’), 4.88, (1H, t, J = 10, H-4’), 4.05, (1H, m, H-5’), 3.11, (2H, dd, J = 3, 7,
SCH2CH2CN), 3.05, (1H, dd, J = 7, 12, H-6’), 2.93 (1H, dd, J = 7, 14, H-6’’),
2.71 (2H, dd, J = 3, 7 , SCH2CH2CN), 2.17, 2.07, 2.06, 2.01, (12H, s, CH3COO)
74
Figure 26.  13C-NMR spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-
tetra-O-acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28).  63 MHz,
CDCl3.  See also Table 4.
Figure 27. 1H NMR spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’,2’,3’,4’-
tetra-O-acetyl-6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (28).  250 MHz,
CDCl3.  See also Table 5.
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C.II.3.  2,6-Bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,4’,6’-tetra-O-acetyl-1’-thio-
b-D-glucopyranosyl)tetrathiafulvalene (29)
Cesium hydroxide (CsOH.H2O) (87.6  mg, 0.52 mmol) in MeOH (10 ml) was
injected to 12 (63.0 mg, 0.12 mmol) in dry and degassed DMF (10 ml) under
nitrogen .  Reaction was stirred for two hours, 23 (214 mg, 0.52 mmol) in DMF
(5 ml) was added and solution stirred for 48 hours.  After removing the solvent
in vacuo, the residue was dissolved in DCM, washed with water, dried with
Na2SO4 , filtered and the solvent evaporated in vacuo.  The residue was
subjected to flash column chromatography using 10 % EtOAC/DCM as eluting
solvents affording brown oil (76 mg, 59.8% yield); Rf 0.38 (10% EtOAC/DCM);
[ ]25°CDa = +62.55 (c = 0.1 DCM);  FAB-MS:  m/z =1098[M+ ]. C40H46O18N2S8
Calculated: C  44.08% H  4.19% S  23.22% N  2.55%
Found: C  48.14% H  5.87% S  23.12% N  3.44%
13C (63 MHz, CDCl3/TMS) d = 170.66-169.38, (CH3COO), 118.86, (C=C), 82.98,
(C-1’), 74.90, (C-2’), 72.66, (C-3’), 69.29, (C-4’), 67.69 (C-2’), 61.78 (C-6’), 31.75
(SCH2CH2CN), 20.69-20.59 (CH3COO), 18.19 (SCH2CH2CN).
1H (250 MHz, CDCl3) d = 5.22, (2H, t, J = 9.5, H-3’), 5.10, (2H, t, J = 9.5, H-4’),
4.99, (2H, dd, J = 8, 9.5, H-2’), 4.42 (2H, d, J = 8.0, H-1’), 4.28 (2H, dd, J = 5,
12, H-6a’), 4.15 (2H, dd,  J = 3,12, H-6b’), 3.72 (2H, m, H-5’), 3.27 (2H, t, J =
6.3, SCH2CH2CN), 2.76(2H, t, J = 6.3, SCH2CH2CN), 2.08 (4H, s, COCH3), 2.05,
4H, s, COCH3), 2.04 (4H, s, COCH3), 1.98 (4H, s, COCH3)
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Figure 28.  13C NMR of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,4’,6’-tetra-O-
acetyl-1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (29), 63 MHz, DMSO-d6.
See also Table 6.
Figure 29.  1H NMR spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’,3’,4’,6’-
tetra-O-acetyl-1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (29).  250 MHz,
CDCl3.  See also Table 7.
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C.II.4.  2,6-Bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-glucopyranosyl)tetra-
thiafulvalene (30)
Sodium (10 mg , 0.43 mmol) in MeOH (100 ml) was injected to 28 (50 mg,
0.045 mmol) in degassed MeOH (10 mL) and the solution stirred overnight.
After removing the solvent in vacuo, a dark brown oily residue was left which
turns black upon standing ( 33.2 mg, 96% yield), Rf = 0.59.  (acetone/water:
1:1).  FAB MS:  m/z 482, [M- 2(C6H11O5) + 2 Na], (C6H11O5 = glucose moiety)
C.II.5.  2,6-Bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-glucopyranosyl)tetra-
thiafulvalene (31)
Sodium (10 mg , 0.43 mmol) in MeOH (100 ml) was injected to 29 (50.0 mg,
0.045 mmol) in degassed MeOH (10 mL) and the solution stirred overnight.
After removing the solvent in vacuo, a dark brown oily residue was left which
turns black upon standing ( 32 mg, 94% yield), Rf = 0.59.  (acetone/water: 1:1).
FAB MS :m/z 482, [M- 2(C6H11O5) + 2 Na], (C6H11O5 = glucose moiety)
C.II.6.  Tetrakis(2’-hydroxyethylthio)tetrathiafulvalene (32)
12 (100 mg, 0.185 mmol) was dissolved in anhydrous DMF (10 mL) in a 100
mL round bottomed flask under dry N2.  Freshly prepared NaOMe (7.4 mL,
0.10 M, 4.5 equiv) were added.  After stirring for 30 minutes at room
temperature.  2-chloroethanol ( ~0.06 mL, 10 equiv) were added through the
septum and the mixture stirred for 14 h at r.t.  H2O (10 mL) were added and
the stirring continued for another 30 min and the mixture was concentrated in
vacuo.  This resulted in an orange oil, which crystallized after the addition of
hexane (4 mL) and Et2O (10 mL).  Isolation and recrystallization in methanol
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gave orange needles; yield:  mp 142.9-143.6°C (Lit.[56] 139°-140°C).  MS (EI)
507.9
1H NMR ( 250 MHz, DMSO-d6/TMS) d = 5.01 (t, 4H, J= 5.5 Hz), 3.60 (m, 8H),
2.96 (m, 8H).  13C NMR ( 63 MHz, DMSO-d6/TMS):  d = 126.94, 109.47 (C=C),
60.30 (SCH2CH2OH), 38.14 (SCH2CH2OH)
C.II.7.  2,6-Bis(2’’-cyanoethylthio)-3,7-bis(2’-carboxymethylthio)tetrathia-
fulvalene (33)
12 (100 mg, 0.185 mmol) was dissolved in anhy DMF (10 mL) in a 100 mL
round bottomed flask under dry N2.  Freshly prepared NaOMe (7.4 mL, 0.10 M,
4.5 equiv) were added.  After stirring for 30 minutes at r.t  ICH2COOH ( 273.3
mg, 1.5 mmol, ~10 equiv) were added through the septum and the mixture
stirred overnight at room temperature (20 minutes after the addition, orange
precipitate starts to form).  H2O  (15 mL) were added and the stirring continued
for another 30 min and the mixture was concentrated in vacuo.  This resulted
in an orange oil, methanol was added and red-orange precipitate formed.  This
was filtered to give a yield : 85.5 mg, (82%); mp 181-182°C
13C NMR (DMSO-d6/TMS): d =169.12 (COOH), 118.93 (C=C), 31.00
(SCH2CH2CN), 18.15, (SCH2CH2CN).  1H NMR (DMSO-d6/TMS) d = 3.70 (s,
COOH), 3.12 (2H, t, J = 7, SCH2CH2CN), 2.88 (2H, t, J = 7, CH2CH2CN), 2.50
(2H, s, CH2COOH).
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Figure 30.  13C NMR spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’-carboxy-
methylthio)tetrathiafulvalene (33).  63 MHz, DMSO-d6.  See also Table 8.
Figure 31.  1H NMR spectrum of 2,6-bis(2’’-cyanoethylthio)-3,7-bis(2’-carboxy-
methylthio)tetrathiafulvalene (33).  250 MHz.  DMSO-d6.  See also Table 9.
HOOCCH2S
CNCH2CH2S S
S SCH2COOH
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80
C.III.  Synthesis of 1,3-Dithiole-2-thione-4,5-dithiolate-Carbohydrate
Derivatives
C.III.1.  4,5-Bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a -D-glucopyranosyl)1,3-
dithiole-2-thione (34)
8 (50 mg, 0.070 mmol) in DMF (5 mL) was degassed, 14 (150 mg, 0.33 mmol)
were added and the mixture was refluxed (120-130°C) for 16 hours under N2.
After removing the solvent in vacuo, the residue was dissolved in DCM, washed
with water, dried with Na2SO4 , filtered and the solvent evaporated in vacuo.
The residue was subjected to flash column chromatography using 10%
EtOAc/DCM .  Yield:  90 mg, 74.3%, mp:  182.6-184°C.  Rf:  (solvent system:
1:1.1:1, hexane:toluene:DCM:acetone). [ ]25°CDa  =+147.6 (c = 0.05M, DCM), FAB–
MS:  m/z = 858 [M+].  C31H38O18S5:  (858.0).
Calculated C  43.34% H  4.42% S  18.65%
Found C  42.35% H  4.15% S  14.33%
 13 C  NMR (63.5 MHz, CDCl3) d = 169.65, 169.58, 169.37, 168.82, (COOCH3),
137.31 (C=C), 88.03 (C-1’), 70.57 (C-2’), 69.86 (C-3’), 69.01 (C-4’), 68.70, (C-5’),
36.93, (C6’H2S), 20.58, 20.47, 20.32, 20.25, (COOCH3).
1H NMR (250 MHz, CDCl3/TMS)6.33 (1H, d, J = 3.6, H-1’), 5.49 (1H, t, J = 10,
H-3’), 5.11 (1H, dd, J = 3.6, 10, H-2’), 5.03 (1H, t, J = 10, H-4’), 4.16-4.08 (1H,
m, H-5’), 3.15 (1H, dd, 3, 14, H-6’), 3.00 (1H, dd, J = 7, 14, H-6’’), 2.33 (3H, s,
CH3), 2.27, 3H, s, CH3), 2.06 (3H, s, CH3), 2.03 (3H, s, CH3).
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C.III.2.  4-(2’’-Cyanoethylthio)-5-(2’,3’,4’,6’-tetra-O-acetyl-1’-thio-b -D-glu-
copyranosyl)-1,3-dithiole-2-thione (35)
Cesium hydroxide (CsOH.H2O) (45.6 mg, 027 mmol) in MeOH (10 ml) was
injected to 11 (33.0 mg, 0.109 mmol)  in degassed MeCN (10 mL) after 30
minutes, 25 ( 111.38 mg, 0.27 mmol) in MeCN (10 ml) was added and solution
stirred  overnight.  After removing the solvent in vacuo, the residue was
dissolved in DCM, washed with water, dried with Na2SO4 , filtered and the
solvent evaporated in vacuo.  The residue was subjected to flash column
chromatography using 10 % EtOAC/DCM as eluting solvents affording yellow
oil.  Recrystallizing in EtOH afforded light yellow needle like crystals (57 mg,
90% yield); mp 178.1-179.3°C; Rf  0.47  (10% EtOAc/DCM) , [ ]25°CDa = +101.88
(c = 0.07 M, DCM), FD-MS m/z=  [M++1] 582, [M++23] 604.  C20H23O9NS5:
(581).
Calculated C  41.30% H  3.99% N  2.41% S  27.54%
Found C  41.43% H  4.54% N  1.80% S  26.00%
13 C NMR (63.5 MHz, CDCl3) d= 169.91, 169.50, 169.26 (2C) (CH3COO), 82.91
(C-1’), 118.81 (C=C), 74.82, 72.59, 69.23, 67.62 (C-2’–C-5’), 61.71 (C-6’), 31.68
(SCH2CH2CN), 20.71, 20.42, 20.38, 20.25 (4-CH3COO), 18.12 (SCH2CH2CN)
1 H (250 MHz, CDCl3)d = 5.23 (1H, t, J = 9.4, H-3’), 5.11 (1H, t, J = 9.4, H-4’),
5.00 (1H, dd, J = 7.9, 9.4, H-2’), 4.43 (1H, d, J = 7.9, H-1’), 4.29 (1H, dd, J = 4,
12, H-6’), 4.21 (1H, dd, J = 4, 12, H-6’’), 3.72-3.65 (1H, m, H-5’), 3.25 (2H, t,  J
= 7, SCH2CH2CN), 2.93 (2H, t, J = 7, SCH2CH2CN), 2.18 (3H, s, CH3COO), 2.15
(3H, s, CH3COO), 2.13, (3H, s, CH3COO), 2.09 (3H, s, CH3COO).
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C.III.3.  4,5-Bis(6’-thio-D-glucopyranosyl)-1,3-dithiole-2-thione (36)
Sodium (10 mg , 0.43 mmol) in MeOH (100 ml) was injected to 34 (50.0 mg,
0.058 mmol) in degassed MeOH (10 mL) and the solution stirred overnight.
After removing the solvent in vacuo, a dark brown oily residue was left which
turns black upon exposure to the atmosphere ( 30 mg, 99% yield), Rf = 0.57
(ethanol/acetone 1/1 v/v). FAB MS m/z 530 [M + 8H].
C.III.4.  4-(2’’-Cyanoethylthio)-5-(1’-thio-b -D-glucopyranosyl)-1,3-dithiole-
2-thione (37).
Sodium (10 mg , 0.43 mmol) in MeOH (100 ml) was injected to 35 (50.0 mg,
0.086 mmol) in degassed MeOH (10 mL) and the solution stirred overnight.
After removing the solvent in vacuo, a dark brown oily residue was left which
turns black upon standing (35 mg, 98 % yield), Rf = 0.70 (ethanol/acetone 1/1
v/v). FAB MS m/z 413 [M+].
C.III.5.  4,5-Bis(2’-hydroxyethylthio)-1,3-dithiole-2-thione (38)
8 ( 500 mg, 0.70 mmol) in acetonitrile (10 mL) were mixed with ClCH2CH2OH (
2 mL)  and heated under reflux until the disappearance of the red color of 8.
After removing the solvent in vacuo, the residue was dissolved in DCM, washed
with water, dried with Na2SO4 , filtered and the solvent evaporated in vacuo.
The residue was recrystallized from ethanol forming yellow-green crystals.
Yield:  280 mg, 70%  m.p.:  73.1-75.7°C. Rf 0.32 (1:1:1:1, DCM/Tol/Acet/Hex),
FAB–MS:  m/z = 287 [M+ + 1].  C7H10O2S5:  (286.0).
Calculated C  29.37% H  3.50% S  55.94%
Found C  28.57% H  3.51% S  55.20%
83
GASPE NMR ( 250 MHz, DMSO-d6/TMS) d= 206.62 (C=S), 136.11 (C=C), 60.07
(2C, SCH2CH2OH), 38.64, 38.50 (SCH2CH2OH)
1H NMR ( 250 MHz, DMSO-d6/TMS) d= 5.05 (t, J = 5.5, 2H), 3.66 (dd, J = 6.3,
12 Hz, 4H), 3.08 (dd, J = 6.3, 12 Hz, 4H)
C.III.6.  4,5-Bis(2’-carboxymethylthio)-1,3-dithiole-2-thione (39)
 8 (700 mg, 1.0 mmol) in acetonitrile (15 mL) were mixed with ICH2COOH (1.1
g, 7 mmol), NaOH (0.3 g, 7.5 mmol) and H2O (7.5 mL) and heated under reflux
until the disappearance of the red color of 8.  CH3CN was removed in vacuo,
HCl (50%, 25 mL) were added with cooling, forming yellow crystals.  The
product was recrystallized by dissolving the crystals in dilute NH3 and slow
addition of HCl (50%). Yield: 74.4%, mp  172-174°C (lit [42] 171-173°C , FAB–
MS:  m/z = 315 [M++ 1], 337 [M++ 23].  C7H6O4S5 (314)
GASPE NMR (250 MHz, DMSO-d6/TMS):   d =  169.61(COOH) 136.50 (C=C),
37.58 (S-CH2)
1H NMR (250 MHz, DMSO-d6/TMS) d = 4.37 (broad, COOH), 3.84 (s, CH2)
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Figure 32. 1C NMR spectrum of 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a-D-
glucopyranosyl)1,3-dithiole-2-thione (34). 63 MHz, DMSO-d6.  See also Table
10.
Figure 33. 1H NMR spectrum of 4,5-bis(1’,2’,3’,4’-tetra-O-acetyl-6’-thio-a -D-
glucopyranosyl)1,3-dithiole-2-thione (34).  250 MHz, CDCl3.  See also Table
11.
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Figure 34.  13C NMR spectrum of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-O-
acetyl-1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35).  63 MHz, DMSO-
d6.  See also Table 12.
Figure 35.  1H NMR spectrum of 4-(2’’-cyanoethylthio)-5-(2’,3’,4’,6’-tetra-O-
acetyl-1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (35).  250 MHz, CDCl3.
See also Table 13.
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C.IV.  MTT Assay
C.IV.1.  Materials and reagents
The following materials were used for the biological assay:
Article Company
Cell culture flasks (162  cm2,
standard cap (3150)
Coster
96 wells flat-bottomed microplate,
catalog number 3596
Coster
Centrifuge tubes, 10 and 50 mL Greiner
Securelock-Eppendorf tubes (1.5 mL) Eppendorf
Bio-freeze vials 1.2 mL Coster
Plastic pippettes, steripette 2, 5, 10,
25 mL
Coster
Pippette tips 10-1000 µL Eppendorf
Combitips 0.5 and 5 mL Eppendorf
Minisart NML filter, 0.2 µm porosity Sartorius
Syringes 2-5 mL B. Braun
Equipment Company
ELISA Microplate Reader (MR 700) Dynatech
Dispenser-Multipippette Eppendorf
Varipette, 10-1000 mL, 10-100 mL Eppendorf
Analytical balance Sartorius
Centrifuge Hettich
Sterile bank Waldner
Incubator for cell culture Heraus
Phase contrast microscope Olympus
Waterbath Kötterman
Shaker Heidolph
Material Company
Neubauer cell chamber Blaubrand
Latex gloves Safe Skin
Pasteur pippettes Hirschmann
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C.IV.2.  Media:
C.IV.2.1.  Cell culture medium:
RPMI 1640
Fetal calf serum  (FCS)  10%
L-glutamine  2 mM
Penicillin  100 IU/mL
Streptomycin  100 IU/mL
C.IV.2.2.  Medium for freezing the cells
Fetal calf serum  (FCS) 90%
DMSO  10%
C.IV.3.  Cell lines
The SK-N-SH cell line was obtained from the American Type Culture Collection,
Virginia.  Eagle's medium with 10-15 % FCS was used previously for its
cultivation.
The SK-N-LO cell line was obtained from Dr. Helson and Dr. Fogh, Memorial
Sloan Kettering Cancer Institute, New York.
C.IV.4.  Methods
C.IV.4.1.  Cell culture
Both cell lines grow adherent to the culture flask.  Each were placed in 650 mL
cell culture flask in RPMI medium with  10% FCS, glutamine100 IU/mL and
penicillin/streptomycin 100 IU/mL.  The flasks were laid down (area:  150 cm2)
for culture growth.  The incubation of the cells was done at 37°C, with an
atmosphere of 5% CO2 and 100% humidity.  The growth was monitored
everyday under the microscope.  The indicator phenol red is present in the
medium to signal for pH changes.  The change in color of the medium from red
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to orange would require a change in the medium.  An overview of the pH value
with the corresponding color of the medium is given:  7.8:  violet, 7.6:  blue-
red, 7.4:  red, 7.0:  orange, 6.5:  yellow.
When the cells are fully grown, it is required to be split into another flask.
C.IV.4.2.  Culture of neuroblastoma cells
Adherently Growing SK-N-SH and SK-N-LO were detached from the culture
flasks as follows:
1. The cell culture medium was removed completely and approximately 2.5 mL
of trypsin was added to each culture flask (150 cm2).  The cells were
incubated with trypsin at room temperature for 5 minutes.
2. The cells were detached from the bottom of the flask by shaking.
3. The effect of trypsin was blocked by the addition of 10 mL  of cell culture
medium.
4. The cell suspension was then centrifuged (10 minutes, 400g).  The
supernatant was removed and the cells were resuspended in 10 mL of cell
culture medium.  The cell count was determined with a Neubauer cell
chamber in the presence of trypan blue.  For this purpose, 20µL of cell
suspension  were mixed with 20 µL of trypan blue.  The cells were counted
in 4 large squares of the cell chamber, whereby  only the non-stained cells
were used to adjust the cell concentration.  Since the volume of one large
square is 0.1µL , the total cell count from 4 large squares was divided by 4
and multiplied by 10,000 in order to get the number of cells per 1 mL .  This
number was finally multiplied by 2 (dilution factor of trypan blue).  A
definite number of cells was used for further culture of the cells, whereas
the rest of the cells was used for experiments.
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C.IV.4.3.  Freezing and defrosting of cells
The cells were removed from the flask as described in C.VII.3.1 and suspended
in FCS containing 10% DMSO.  The suspension is placed in 1 mL aliquot in
"bio-freeze vials", wrapped in cell wool and placed in a deep-freezer (-70°C) for
24hours.  Further freezing would require liquid nitrogen.
The cell samples are defrosted by quick immersion in a water bath (37°-40°C)
and incubation for 40-60 seconds.  The defrosted suspension is then placed in
10 mL centrifuge tubes and 10 mL of the medium is added.  The cell
suspension is centrifuged, the medium removed, the cell pelletized and fresh
medium added.  The new cell suspension can be placed in 2-3 culture flasks
and cultivated in 35-50 mL medium.
C.IV.4.4.  Preparation of MTT solution
5 mg of MTT are dissolved in 1 mL of PBS (phosphate buffered saline) .  The
solution should be filtered through a 0.2 µm filter, wrapped in aluminum foil
(MTT is a light sensitive substance)  and stored at 4°C.
C.IV.4.5.  Preparation of isopropanol-triton X-100 solution
0.1 M HCl in isopropanol and 10% Triton X-100 are mixed.  The solution
should be stored at room temperature.
C.IV.5.  Cytotoxicity test using the MTT assay
C.IV.5.1.  MTT assay with neuroblastoma cells
200 µL of cell suspension (5.0 x 105 cells/mL of cell culture medium) are
placed with a dispenser Multipipette (Eppendorf) into each well of the 96 well
microtiter plate,  3 wells are filled with cell culture medium only and are used
as blank.  The plate is incubated overnight in an incubator at 37°C , 5% CO2
and 100% humidity.
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The next day, the substances to be tested are added in 10 µL volumes.  In the
control wells, the same volumes of PBS were added instead of the substances.
The 96 well microtiter plate is further incubated for 48 hours at 37°C, 5% CO2
and 100% humidity.
After 48 hours of incubation, the cell culture medium was removed completely
by a Pasteur pipette connected a vacuum pump.  Then, 100µL of MTT solution
(MTT stock solution, diluted to 1:9 with RPMI-1640) is added into each well.
The microtiter plate was further incubated for 3 hours in the incubator.
During this time, MTT is transformed into formazan, which microscopically
show blue crystals between the cells at the bottom of the wells.
Then, 100 µL of isopropanol solution were added into each well and the plate
was shaken horizontally for further 8-10 hours (usually overnight) at room
temperature.  During this time, formazan crystals are dissolved.  After this
step, microscopically no crystals should be present in any well.  In all wells
there is a homogenous colour to be observed.
Finally, the absorbance of the colour in each well was measured by a
Microplate reader (MR 700) in a dual mode with a reference  wavelength at 550
nm (filter number 5) and a test wavelength at 630 nm (filter number 4).
The absorbance of the control was taken as 100% survival and the values given
are the ratios between the absorbance of the test substance and the control.
There were four independent experiments, each was performed four fold.  The
first trial was performed using the freshly prepared solution of the synthesized
derivatives.  The samples were then stored at –20°C.  The second trial was done
from a sample that was stored for 4 days, the third one after 8 days of sample
storage, and the fourth one after 12 days of sample storage.  The average from
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4 replicates in 4 independent trials and the +/-  standard deviation was
plotted.
C.IV.6.  ELISA multiwell spectrophotometry
The light absorption of the sample in the 96 well microtiter plate was measured
in a MR 700 Microplate Reader from Dyna.  The absorption of the sample was
measured at two wavelengths using 550 nm as the reference and 630 nm as
the test wavelength.
Figure 36.  Schematic representation of the Microplate-Reader MR 700.
Lamp
LensTungsten
Halogen
Prism
Microplate
Filter
Silicon Photo Detector
Analog-Digital 
Transformation
~32 Measurements
per well
Computer
Blanking
Information
& Memory
Reading in 
Absorption units
Alphanumeric
Display
Sample
Reference
92
C.IV.7.  Activity testing data
Table 21.  Effect of different concentrations of 2,6-bis(2’’-cyanoethylthio)-3,7-
bis(1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (31) on % of survival of SK-N-
LO neuroblastoma cells.  The absorbance of the control was taken as 100%
survival and the values given are the ratios between the absorbance of the test
substance and the control.  The average from 4 replicates in 4 independent
trials and the +/-  standard deviation are given.  First trial was performed
using the freshly prepared solution.  The second trial was performed in a
sample that was stored for 4 days.  Third trial was done after 8 days of sample
storage.  Fourth trial was performed after 12 days of sample storage.
Concentration
µM/mL
Trial 1 Trial 2 Trial 3 Trial 4
3.00 0.98 ± 0.10 5.49 ± 0.70 13.93 ± 1.40 13.54 ± 1.90
1.50 14.54 ± 3.30 35.71 ± 2.10 73.57 ± 7.00 56.60 ± 3.90
0.30 18.79 ± 4.00 38.46± 7.30 81.96 ± 5.10 71.88 ± 5.50
0.030 97.00 ± 9.10 82.41± 9.80 95.53 ± 4.70 84.02 ± 2.10
Table 22.  Effect of different concentrations of 2,6-bis(2’’-cyanoethylthio)-3,7-
bis(6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (30) on % of survival of SK-N-
LO neuroblastoma cells. The absorbance of the control was taken as 100%
survival and the values given are the ratios between the absorbance of the test
substance and the control.  The average from 4 replicates in 4 independent
trials and the +/-  standard deviation are given.  First trial was performed
using the freshly prepared solution.  The second trial was performed in a
sample that was stored for 4 days.  Third trial was done after 8 days of sample
storage.  Fourth trial was performed after 12 days of sample storage.
Concentration
µM/mL
Trial 1 Trial 2 Trial 3 Trial 4
3.00 5.89 ± 0.20 9.89 ± 0.60 24.82 ± 1.10 24.31 ± 1.20
1.50 10.78 ± 0.60 25.30 ± 0.40 27.14 ± 2.40 44.79 ± 0.70
0.30 37.25 ± 0.70 63.73 ± 5.00 78.75 ± 4.10 87.80 ± 7.40
0.030 45.58 ± 1.10 113.00 ± 6.60 81.25 ± 4.70 84.38 ± 5.20
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Table 23.  Effect of different concentrations of 2,6-bis(2’’-cyanoethylthio)-3,7-
bis(1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (31) on % of survival of SK-N-
SH neuroblastoma cells.  The absorbance of the control was taken as 100%
survival and the values given are the ratios between the absorbance of the test
substance and the control.  The average from 4 replicates in 4 independent
trials and the +/-  standard deviation are given.  First trial was performed
using the freshly prepared solution.  The second trial was performed in a
sample that was stored for 4 days.  Third trial was done after 8 days of sample
storage.  Fourth trial was performed after 12 days of sample storage.
Concentration
µM/mL
Trial 1 Trial 2 Trial 3 Trial 4
3.00 1.10 ± 0.40 1.65 ± 0.10 3.93 ± 0.50 4.32 ± 0.20
1.50 1.10 ± 0.10 3.30 ± 0.10 5.76 ± 2.30 7.40 ± 0.80
0.30 7.20 ± 0.40 4.79 ± 1.30 8.80 ± 0.90 78.39 ± 2.00
0.030 85.50 ± 6.40 88.30 ± 6.50 102.00 ± 10.50 113.00 ± 1.80
Table 24.  Effect of different concentrations of 2,6-bis(2’’-cyanoethylthio)-3,7-
bis(6’-thio-a-D-glucopyranosyl)tetrathiafulvalene (30) on % of survival of SK-N-
SH neuroblastoma cells. The absorbance of the control was taken as 100%
survival and the values given are the ratios between the absorbance of the test
substance and the control.  The average from 4 replicates in 4 independent
trials and the +/-  standard deviation are given.  First trial was performed
using the freshly prepared solution.  The second trial was performed in a
sample that was stored for 4 days.  Third trial was done after 8 days of sample
storage.  Fourth trial was performed after 12 days of sample storage.
Concentration
µM/mL
Trial 1 Trial 2 Trial 3 Trial 4
3.00 5.89 ± 0.30 6.44 ± 2.40 4.21 ± 1.0 8.33 ± 0.40
1.50 9.21 ± 1.20 6.61 ± 0.60 8.96 ± 1.2 12.04 ± 1.06
0.30 13.25±1.90 13.90±1.00 17.50 ± 2.9 66.67 ± 3.90
0.030 100.00±3.60 52.00 ± 16.40 90.77± 11. 2 119.00± 3.80
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D.  Abstract
Tetrathiafulvalenes (TTF) Figure 1. and related heterocycles have received
much interest due to their unique electron-donating capabilities
Figure 1.  Structure of tetrathiafulvalene (TTF).
As such, they have a widespread application in modern material science
chemistry: as a component of macrocycles, molecular metals and
superconductors at low temperatures. Due to their planar structure
(intercalation with DNA bases ) and their redox properties they also might be
potential interesting drugs in cancer therapy.
However, no studies have been made so far on the possible application of TTF
to biological systems because of the insolubility of the known derivatives in
water. The main task of this thesis was, therefore, to synthesize and
characterise novel water-soluble TTF- and 1,3-dithiole-2-thione-4,5-dithiolate
(DMIT) - carbohydrate derivatives. In an attempt to determine the biological
activity of TTF-containing and related compounds.  2,6-bis(2’’-cyanoethylthio)-
3,7-bis(6’-thio-D-glucopyranosyl)tetrathiafulvalene (30) and 2,6-bis(2’’-cyano-
ethylthio)-3,7-bis(1’-thio-b-D-glucopyranosyl)tetrathiafulvalene (31) were found
to be cytotoxic against SK-N-LO and SK-N-SH neuroblastoma cells using the
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium-bromide) assay.
With this test system, proliferation and vitality of cells can be measured in vitro
S
S
S
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due to the capability of vital mitochondria to reduce MTT to formazans. Using
this test system LD50 values of substances 31 and 31 were found ~0.07 to 2.00
µM/mL, which is comparable to those of the well-known cytotoxic drug
doxorubicin.  On the other side, the DMIT-carbohydrate conjugates 4,5-bis(6’-
thio-D-glucopyranosyl)-1,3-dithiole-2-thione (36) and 4-(2’’-cyanoethylthio)-5-
(1’-thio-b-D-glucopyranosyl)-1,3-dithiole-2-thione (37) did not exhibit any
cytotoxic activity. This may be due to the different structural properties of
DMIT compounds compared to compounds 30 and 31.
In summary: 2,6-bis(2’’-cyanoethylthio)-3,7-bis(6’-thio-D-glucopyranosyl)-
tetrathiafulvalene (30) and 2,6-bis(2’’-cyanoethylthio)-3,7-bis(1’-thio-b-D-gluco-
pyranosyl)tetrathiafulvalene (31) are cytotoxic to both human neuroblastoma
cell lines tested with the MTT assay. It may be that these effects can be further
enhanced by combination with other redox active substances (Redox cycling).
This question should be answered in further in vitro- and in vivo- experiments.
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E.  Zusammenfassung
Tetrathiafulvalen (Abb. 1) und verwandte Heterozyklen haben durch ihre
spezielle Fähigkeit des Elektronentransfers grosses Interesse hervorgerufen.
Abb. 1.  Struktur von Tetrathiafulvalen (TTF).
Aus diesem Grund haben sie weitgefächerte Anwendungen in der modernen
Materialstoffchemie als Komponenten von Makrozyklen, als "molekulare
Metalle" und als Tieftemperatur-Supraleiter gefunden. Aufgrund ihrer planaren
Struktur (mit der potentiellen Möglichkeit zur Intercalation zwischen DNS-
Basen) und ihrer Redox-Eigenschaften könnten sie auch als cytotoxische
Verbindungen in der Krebstherapie von Interesse sein. Allerdings sind bisher
noch keine diesbezüglichen Applikationen von TTF beschrieben worden, u.a.
wegen der Unlöslichkeit der existierenden Verbindungen in Wasser.
Das Hauptziel der vorliegenden Arbeit war es, neue wasserlösliche TTF und
1.3-dithiol-2-thion-4.5-dithiolat (DMIT)- Kohlenhydrate zu synthetisieren und
zu charakterisieren, um die biologische Aktivität von TTF- Derivaten und
verwandten Verbindungen zu bestimmen. Dabei zeigte sich, dass zwei TTF
enthaltende Verbindungen 2.6-bis(2’’-cyanoethylthio)-3.7-bis(6’-thio-D-
glucopyranosyl)tetrathiafulvalen (30) und 2.6-bis(2’’-cyanoethylthio)-3.7-bis(1’-
thio-b-D-glucopyranosyl)tetrathiafulvalen (31) zytotoxisch auf die beiden
humanen Neuroblastomzelllinien SK-N-LO und SK-N-SH reagierten. Unter
S
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Verwendung des MTT-Testes, der die Vitalität und Proliferation durch
Reduktion von MTT zu Formazanen durch Mitochondrien vitaler Zellen mißt,
wurden durch Substanz 30 bzw 31 LD50 Werte von ~0.07 bis 2.00 µM/mL
erhalten, was vergleichbar ist mit Werten, die bei Verwendung des etablierten
Zytostatikums Doxorubicin erhalten wurden. Im Gegensatz dazu zeigten die
synthetisierten DMIT-Kohlenhydrat-Derivate 4.5-bis(6’-thio-D-glucopyrano-
syl)-1,3-dithiole-2-thione (36) and 4-(2’’-cyanoethylthio)-5-(1’-thio-b-D-gluco-
pyranosyl)-1,3-dithiole-2-thione (37) keine zytotoxische Aktivität.
Möglicherweise sind die strukturellen Unterschiede zwischen beiden
Substanzklassen für dieses unterschiedliche Verhalten verantwortlich.
Zusammenfassend läßt sich sagen, dass zumindest die Verbindungen 2.6-
bis(2’’-cyanoethylthio)-3.7-bis(6’-thio-D-glucopyranosyl)tetrathiafulvalen (30)
and 2.6-bis(2’’-cyanoethylthio)-3.7-bis(1’-thio-b-D-glucopyranosyl)tetrathia-
fulvalen (31) eine ausgeprägte Zytotoxizität in vitro gegenüber den beiden
untersuchten humanen Neuroblastomzellen zeigten. Möglicherweise lassen
sich diese Effekte durch Kombination mit anderen Redox-aktiven Substanzen
im Sinne eines Redox-Cycling weiter steigern. Die Beantwortung dieser Frage
muß weiterführenden in vitro- und in vivo- Untersuchungen vorbehalten
bleiben.
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